Agranulocytosis : a review with special consideration to etiology and treatment by Wingett, Wendell T.
University of Nebraska Medical Center 
DigitalCommons@UNMC 
MD Theses Special Collections 
5-1-1939 
Agranulocytosis : a review with special consideration to etiology 
and treatment 
Wendell T. Wingett 
University of Nebraska Medical Center 
This manuscript is historical in nature and may not reflect current medical research and 
practice. Search PubMed for current research. 
Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses 
 Part of the Medical Education Commons 
Recommended Citation 
Wingett, Wendell T., "Agranulocytosis : a review with special consideration to etiology and treatment" 
(1939). MD Theses. 783. 
https://digitalcommons.unmc.edu/mdtheses/783 
This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It 
has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For 




Special Consideration to 
Etiology and Treatment 
By 
Wendell T. Wingett 
SENIOR THESIS 
PRESENTED TO THE COLLEGE or 











Predisposing Causes g 
Organisms as a Cause 11 
Hyperergio Inflammation 26 
Congenital and Familial Bone Marrow Inadequacy 2! 
Endocrine Disturbances 29 
Itiologic Importance of Drug Therapy 30 
Endogenous Disturbances in the Bone Karrow 5! 
PATHOLOGY 63 
SYMPTOMS, SIGHS, ARD BLOOD PIOTURE 65 
PROGNOSIS 69 
TREATDHT 70 
Treatment of Local Lesions 71 
Kiscellaneous Agents Used 72 
Blood Transfusions 75 
Irradiation of Bones 76 
Liver Extract 7g 
Nucleotide Therapy SO 





Although it has been seventeen years since Werner 
Schultz, (108) in Germany, described a clinical syndrome, 
which he called agranulocytosis, and which he believed 
was a disease entity, there remains considerable confusion 
as to many phases of the condition. Kany writers have 
refused to consider it as a true disease entity, and in 
reviewing the literature of the published case reports 
the reason for this becomes quite obvious. Kany authors 
have included all cases that show a leultopenia and neutro-
penia regardless of the clinical picture. Such reports 
lead one to the conclusion that they are dealing with a 
group of diseases. 
The literature is especially voluminous in regard 
to the etiology and treatment of agranulocytosis. Kany 
ideas have been offered but few have been generally ac-
cepted. It is for this reason that the major portion of 
this paper will be given over to a review of the estab-
lished observations concerning the etiology and treatment 
with an attempt to present the statue of these phases at 
the present time. For the sake of completeness, brief 
consideration will be given to the history, pathology, 
symptoms and signs, and the blood picture of the disease. 
Agranulooytosia may be defined aa a grave condition 
of k~own and unknown etiology, characterised by a marked 
reduction of the total number of white blood cells, and 
a great reduction in the percentage of granulocytes, ac-
companied by aplastic, normal or hyperplastic myeloid 
tissue. following the peripheral neutropenia there may 
be any number of lesions and symptoms which might follow 
the removal from the body of such an important defense 
mechanism. Characteristically these lesions consist of 
necrotic ulcerations in the oral cavity but may also oc-
cur on the skin or mucous membranes elsewhere in the 
body. The disease may be aoute, chronic or recurrent. 
IODIOLATURI 
Werner Schultz, (108) in 1933, proposed the name 
agranulocytoais. The literature contains considerable 
criticism of this term and consequently many different 
ones have been offered in its stead. friedemann, writ-
ing in 1933, being impressed by the usual severe local-
ization of the process in the throat, suggested the name 
"agranuloqt1c angina•. ( 121) Thia name has been used 
in the literature nearly as often as the original term 
given by Schult&. The term agranulocytosis came into the 
nomenclature, no doubt, on account of its brevity; many 
authors, however, believe it incorrect. Victor Schilling 
(107) said: 1 the term •agranulocytosis' has come into 
the nomenclature on account of its brevity. It is in-
correct; the name of •agranulooytes• was originally chos-




By 1agranulocytosia 1 is meant an .increase in these atyp-
ical neutrophils which is not intended. 1 The name agran-
ulooytic angina has also been criticized because of its 
intrinsic ambiguity, and because it implies that one ia 
dealing With an infection of the mouth which causes a 
neutropenia, instead of with a syndrome of indefinite 
etiology. Stillman, (118) and Baldridge and Needles, (a) 
have pointed out that the throat symptoms are not always 
present. Because of these confusing terms, many others 
have been suggested. Schilling (107) has stated that 
"Jlalignant neutropenia1 is a more descriptive and appro-
priate term. Dameshek and Ingall (19) also prefer that 
term. Baldridge and Needles (2) have called it 1 idio-
pathic neutropenia1 • litz-Hugh and Xrumbhaar (36) prefer 
the designation 1 pernia1oua 1eukopenia1 which 1 silggests 
certain analagies between this disease and pernicious 
anemia•. Linthicum (75) suggested the name •pyocyan1o 
stomatitis with agranulocytio leulcopenia1 because of the 
etiological importance he attaobed. to the Bacillus pyo-
oyaneoua. Pelnar, (88) in 1925, called the condition 
•malignant leultopenia•- Because he belieYed that it was 
only one type of sepsis, reer (33) preferred the term 
•sepsis agranulocytioa•. In order to give due credit to 
the man who a.roused interest in the condition, Rueper, l49) 
has chosen the ne.me, 1 .lgranulooytosis (Schultz)•. 
Roberts and Kracke (100) prefer 11granulopen1a". 
Rosenthal, (104) in his olasaifioatlon made according 
to the clinical manifestations and course, divided neu-
tropenia into malignant (fatal) and benign (recovered) 
cases. In reference to this classification, Beck (3) 
stated that it might be well further to divide these into: 
two main classes as follows: l. primary benign and pri-
mary malignant neutropenia, the true cases of benign and 
malignant neutropenia, in which the etiology is unknown; 
a. secondary benign and secondary malignant neutropenia, 
the oases 1n which the etiologic agents are evident or 
in which one is dealing with examples of well recognized 
clinical entities. 
HISTORY 
If agranulocytosis had existed to any great extent 
prior to 1922, it undoubtedly would have been described 
long before, since the disease runs such a dramatic course 
and often te~minates fatally. Blood counts have been made 
as a routine procedure in most large hospitals for the 
past fifty years. Werner Schultz, (108) in 1923, first 
fully described four oases in middle aged women character-
ized by gangrenous throat lesions, severe leultopenia, a 
decrease or absence of granular cells in the peripheral 
blood, and a rapid septic course with death in from two 
to seven days. He. noted the frequent association of jaun-
dice, the persistence of a normal red blood cell count 
4 
and the scarcity of myeloid cells found in the bone 
marrow at postmortem examination. Schultz is thus given 
credit for recognizing the syndrome later named agran-
ulocytic angina by Friedemann, but, Pepper (90) states: 
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•no one believes that the condition had not previously 
been seen•. AD editorial in the Journal of the .American 
Kedioal Association (31) quotes Turk as describing simi-
lar oases in 1907, although he did not distinguish them 
from the commoner leukopenia of overwhelming infection. 
Pepper, (90) in his history of agranulooytic angina, ataied 
that standard laryngologic works of fifty years ago appar-
ently described this disease under the heading •putrid sore 
throat• and •gangrenous angina", and he said that Kaotenzie, 
in his manual of diseases of the throat and nose, credi-
ted Gubler, in 1857, and Trousseau, in 1865, with having 
clearly distinguished the disease from diphtheria. 
In 1902, Brown. (13) reported •a fatal case of acute 
primary 1.nfeotioua phal"Jngitis with extreme leukopenia•. 
The case was that of a 28 year old married woman who died 
seven days after the onset of a sore throat. At the on-
set she experienced chilliness and a sudden rise of temP-
erature to 103. The spleen and lymphnodes were slightly 
enlarged. The blood picture showed: leukocytes 1000 with 
one per cent polymorphonucleare, 83 per cent small lympho-
cytes and 16 per cent large lymphocytes. On the third 
day·of the illness the leukocytes were 400 and on the 
fourth day they were 320. The temperature at that time 
was 105.4. There was a gradual increase in swelling of 
the tonsils and pharynx. Cultures of the throat showed 
Staphylococcus aureus and al.bus. The urine showed al-
bumin, casts and red blood cells. On the seventh day 
day •so few leukocytes were found that neither a fair 
estimate of the total number could be made nor were 
enough found on six coverslips to make a differential 
count•. The Patient died on the seventh day from edema 
of the glottis. 
.. Leale, ( 72) in 1910, reported a case in a male child 
two and one-half months old under the title, 1Recurrent 
furunoulosis in an Infant Showing an Unusual Blood Pic-
ture •. He described the case of a baby who was subject 
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to repeated attacks of furunculosie, with accompanying 
fever and prostration all out of proportion to the clinical 
findings, and who also presented the unusual blood picture 
of leukopenia and lymphooytosis without other marked blood 
changes. He was at a loss to explain the unusual blood 
changes and carefully ruled out lymphatic leukemia, malaria, 
rickets, scurvy, and infectious disease. He concluded: 
1 In all probability, the fever is to be accounted for by 
the toxemia generated by the staphylococcus pyogenes aur-
eus during the attacks of furunculosis, but this does not 
satisfactorily account for the peculiar blood findings.• 
Baldridge and Needles (2) reported a case that occurred 
in 1910, pointing out that in former years it either was 
overlooked because the bloOd was not examined, or was 
interpreted as a &Jlllptom of exhaustion of the bone marrow, 
aleultemio leukemia or aplastic anemia. 
In 1923, Schultz (108) reported the four cases as 
described previously, and applied the term agranulocytoais, 
and he stated the belief that it was a distinct clinical 
entity. from that date interest in this symptom complex 
has continually increased. In 1924, Lovett (76) reported 
the first case in this country following Schultz• des-
cription of the syndrome. Sbe reported that about a dozen 
oases of the disease bad been reported in Germany, and 
that her case was a similar one. She stated that the main 
features were ulcerative angina, usually accompanied by 
icterus, a great reduction in the white blood cells, 
af f eoting chiefly the polymorpbonuolear leukocytes and a 
~atal outcome after an acute course. Sbe added that there 
was no anemia and that the granular cells were absent not 
only from the blood, but also from the bone marrow. Since 
her report in 1924, many cases have been reported in this 
country and abroad and many theories as to the pathogene-
sis and treatment suggested. 
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Further interest was aroused in this country following 
the report of R. R. Kracke, (65) in 1931, in which he 
first drew attention to the fact that his patient had 
used large amounts of benzene ring drugs for three years 
preceding her illness, and stated that the association 
between her illness and the drugs should be considered 
of etiological importance. Plumer's (93) report of a 
fatal case of agranulooytoaia in April, 1937, which oc-
curred following the administration of sulfanilamide, 
marked the opening of the latest chapter in the history 
of this interesting condition. 
PATHOGENESIS 
In reviewing the literature one finds many explan-
ations and hypotheses of the pathogenesis of agranulo-
cytosia. An attempt has been made to group these hypo-
theses so that they may be presented more clearly. 
Predisposing Causes.-- It is exceedingly difficult 
to extimate the true incidence of the disease, first 
because an unknown number of oases are not recognized 
owing to the lack of an examination of the blood and, 
second, because all oases in which there is a marked 
leukopenia cannot be classified as instances of true 
agranulocytosis. ror example, Doan (27) stated that only 
twenty percent of patients with leukopenia referred to 
his clinic have true agranulooytosis. It should be em-
phasized that extreme leukopenia may occur secondary to 
8 
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sepsis in cases of various diseases of the blood, such 
as aplastic anemia, aleultem1o leukelll1a and pernicious 
anemia. (121) l'itz-Bugh and Oomroe (35) regard leukopenia 
which occurs in association with those blood disease• or 
following the therapeutic use of arsenic or gold pre-
parations, or after exposure to benzene as a •mere heaato-
logical manifestation• of some other disease and not 
agranulocytos1s. 
Schultz described the condition as occuring in middle 
aged women. Hueper .(49) reviewed 125 oases he found in 
the literature in the six years following Schultz's orig-
inal article and oonclud.ed that 77.5 per cent of the caaes 
had occurred in women. Xastl1n, (62) in 1927, in a sta-
tistical review of the reported oases at that time found 
43 oases reported with 34 of the oases appearing in females, 
or 78 per cent. Jackson (53) found that 82 per cent of 
the reported oases up to 1937 had been women. •rour women 
to one man• is the sex incidence as given by Kracke. (68) 
Roberts and Xracke (100) studied the problem of granulo-
penia in 8 1000 ambulatory private patients, and found that 
one of every four patients in a general practive may be 
expected to have a mild granulopenia. However, they found 
that only 56 per c·ent of the mild granulopenias occurred 
in female patients. Beck (3) concluded that in the final 
analysis, it may be foun4 that neutropenia, chronic and 
acute, does not predominate in either sex. 
Jackson (53) found that 76 per cent of the oases 
were in patients between the ages of 38 and 65 years. 
l:astlin (62) found the average to be 46 years. l:racke 
(66) stated that it may occur in infants or the aged. He 
has observed a patient 72 years old with agranulocytosis. 
Beck (3) stated that practically all of the typical oases 
of primary benign and malignant neutropenia have occurred 
in the fourth decade of life--from 41 to 58 years of age. 
Jackson (53) observed that most of the cases have 
occurred in obese women complaining of gall bladder symp-
toms. Beck (3) also mentions the coincidence of previous 
disease of the liver and the gall bladder with malignant 
neutropenia. In his review of the 1DC1dence of the dis-
ease, Xastlin (62) found a negative history of past ill-
ness in 62.8 per cent of the oases. There seems to be no 
definite relationship of agranulocytoais to season. Bo..,. 
'ever, Kracke (66) believes that it may be somewhat more 
prevalent in the winter because of the 1 frequent associa-
tion with influenza•. As to geographical limitation 
Kracke stated that 80 per cent of the reports are found 
in Germa.n and American literature. He added that it·was 
comparatively infrequent in France and England, rare in 
Italy, and extremely rare in the Orient. l:racke believes 
that this distribution can be correlated to the usage of 
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organic chemical oompounda 1 because 1 in Germany and the 
United States is found the widest usage of organic chem-
ical compounds and aniline dye products•. Similarly, 
Beck (3) lists as other predisposing causes those drugs 
and chemicals containing the benzene ring, the arsenicala 1 
trinitrotoluene, X-rays etc. She also believed that 
•certain infections• might be predisposing causes; such 
oases she groups under the headings of secondary benign 
and secondary malignant neutropenia. 
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Kracke (66) finds th&t the condition seems peculiarly 
prevalent in 1 ladies and gentlemen of leisure• or the 
1 better class•.. He also states that the disease is prac-
tically confined to the white race. lladison and Squier (78) 
have found the condition especially prevalent in doctors, 
nurses, drllggists,students, and other people associated 
with the medical profession. 
Organisms as a Cause.-- The first reports of.agran-
ulocytosis show that the authors considered the condition 
as an infectious disease or at least the result of some 
form of sepsis. Schultz, with the idea that a nervous 
factor was involved, stated.: 1 It may be assumed that the 
affection involves an extensive injury of the spinal cord 
in the domain of the granulocytic system, caused by in-
fection•. (40) Lovett,in 19241 (76) in the first report 
of the disease made in this country, said: 1 Is it a local 
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infection with a specific organism which produces severe 
gangrenous lesions, and has a toxic effect on the granulo-
cytes, or is it primarily an injury to these cells at the 
site of their formation, with a consequent lack of general 
resistance, so that any infeo'tion goes on to necrosis and 
finally deathT 1 She obtained Bacillus pyocyaneous in 
cultures from the oral lesions and from the spleen and 
attached great significance to this discovery. Experi-
mentally Lovett claimed that this organism had the power 
of reducing the leukocytes in the blood of guinea-pigs, and 
causing degeneration of leukocytes in the peritoneal cavity. 
She concluded: "The disease appears to be due to an injury 
to the leukopoietic element of the bone marrow, with low-
ered bodily resistance and necrosis in various parts. The 
etiology and pathogenesis are not explained, but from the 
similarity of all cases so far reported, one must regard 
it as a clinical entity.• 
Koore and Wieder, (83) in 1925, reported a case of a 
. 
woman, aged 42, who recovered from a first attack but died 
of an attack two years later. J'rom their observations .of 
this case, these authors stated as to the etiology of the 
condition:"nothing definite has been found; it seems 'tha.t 
an infectious toxin having an affinity for, and spending 
its force on, the neutrophil producing structure of the 
bone marrow is the important factor in causing the disease•. 
Zadek, (133) in 1925, concluded from the atypical cases 
of agranulocytosis, that it was not an independent disease, 
but only •an abnormal type of reaction•. Piette, (91) in 
1925, after histological examination of the liver, spleen, 
kidney, stomach, auprarenal and ovary from Skiles'(l14) 
Case, concluded: 'As f~ as the unfortunately incomplete 
microscopic examination permits me to form an opinion, 
the following is suggested as the possible pathogenesis: 
13 
The lesions were due to bacterial emboli and were but 
secondary lesions as a consequence of the septico-pyemia. 
Bacilli enter the human organism by some unknown route, 
rapidly destroying all the polymorphonuclear leukocytes; 
then they multiply and give rise to numerous embolisms 
throughout the body, meeting with no opposition or reac-
tion. Only the reticulo-endothelial system of the spleen 
and to a lesser degree of the liver, which show progress-
ive changes, make any attempt to combat the invader. The 
lymphocytes which are immune to the destructive virus are 
unable to entirely defend the body. Some elimination occurs 
through the kidneys, where the bacilli are moat abundant 
and where they are found in large numbers within the ex-
cretory ducts.• Piette (91) was tlnable to obtain positive 
blood cultures and thus 1 identify the causal organism". 
He said: "if they belong to the Bacillus pyocyaneous 
species they must possess some peculiarities in their 
biologic properties.• 
Pelnar (88) described a case of acute leukemia, in 
1934, with a low leukocyte count (dropping from 4,?50 to 
1,070) and a low percentage of neutrophils. Be felt that 
the low neutrophil counts seemed to be especially malig-
nant when combined with low absolute counts. He did not 
feel, however, that agranulocytos1s deserved separation 
as a different entity but grouped all the septic or leu-
·kemic conditions with this syndrome under the name, 
•malignant leukopenia•. leer (33) noted leukocyte counts 
below 3,000 in 186 of 29, 498 patients (0.63 per cent), 
among them 13 patients with counts below 1,000. All of 
the 13 died shortly afterward, with the exception of one 
woman with Banti's disease. reer believed that agranulo-
oytosis was only one type of sepsis. 
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Blanton, (6) in 1923, observed a 60 year old man with 
an unexplained iemp~rature of 101, a slightlJ red and sore 
throat, and marked prostration. There were no definite 
localizing symptoms or signs. The leukocyte count was 
1,340 with an entire absence of pol711orphonuclears. Ten 
days later fiuctuation was noted at the aide of the neok 
and pus laden with hemolytic staphylococci was evacuated. 
Although multiple abscesses developed, the patient even-
tually recovered, and the blood picture changed to normal. 
Blanton concluded: ~This might be cited as an illustration 
of an extreme leuoolysis due to specificity of a bacterial 
poison for white cells in the blood stream and bone 
marrow.• In 193?, Bart (45) reported two cases of 
agranulooytosis oocurring in sisters, ages 32 and 42. 
Blood cultures gave a pure growth of lriedlander•s ba-
cillus. The author believed that these cases were real 
septicemias and that the low blood count was merely in-
dicative of an overwhelming infection. Linthicum, (75) 
in 1927, wrote: •agranulocytosis may be associated with 
a stomatitis caused by any of the pyogenic organisms•. 
He believed, however, that there was a definite clinical 
entity, somewhat similar, which was always fatal and. 
caused by the Bacillus pyocyaneous; thus he gave it the 
name •pyocyanio stomatitis with agranulocytic leukopenia•. 
15 
Sachs, (106) writing in the lebraska State Kedioal 
Journal in 1928, said that agranulooytosis was •probably 
not a disease entity but the failure of the bone marrow 
to respond to a severe infection of unknown etiology•. 
He believed that the condition was not especially rare 
and that in all probability it was being mis-diagnosed as 
streptoooooio sore throat. · Be was also of the opinion 
that agranulooytosis was very sillilar to a llilder group 
of oases called 1 infectioua mononucleosis' and that in all 
probability both were due to the same etiological factor. 
StillJJail, (118) in 1928, expressed the belief that agran-
ulocytosia was probably related to monocytic angina and 
glandular fever, and that it might represent the severe 
form of these conditions. He thought that the condition 
was a special form of reaction on the part of the hemato-
poietic system to infection, rather than the result of 
the activity of a special infective agent. He concluded: 
1 Agranulocytosis is probably due to the activity of some 
extermal stimulus operating in individuals exhibiting a 
constitutional predisposition' and 1 ihis external stimu-
lus is most frequently some form of infection, and oon-
di tions are suoh that even the Bacillus pyooyaneous may 
at times play a significant part in the etiology•. 
16 
In 1928, Heuper (49) made an extensive review of the 
subject and concluded that the majority of workers up to 
that time were of the opinion that the condition was an 
infectious disease and represented a septicemia with an 
atypical reaction of the hematopoietio system due either 
to bacteria with a special affinity and toxicity to the 
granulocytic system or to an atrophy or hypoplasia of this 
organ because of the presence of a septic infection. 
According to his study, the investigators in the field 
believed that the bacterial causes were either specific or 
non-specific. Dayton, (23) in the same year concluded 
that absence or reduction of granular cells might be caused 
by a variety of toxic agents including bacterial invasion. 
Rose and Houser, (102) stated in 1929; 1 The available 
evidence does not justify a conception of so-oalled 
agranulocytos~a or agranulocytic angina as a specific 
disease entity. On the contrary, the known faots con-
cerning the reported cases would indicate that the pic-
ture produced is the result of non-specific reaction to 
an infection of unusual absolute or relative virulence, 
and that a variety of infecting organisms may possibly 
play a part in its production.• 
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Keyer and Rosenberg, (80) in 1930, would not believe 
that the condition was a disease entity and were 1 inclined 
to view it as a terminal reaction in a subject who had 
had a previous debilitating disease or overwhelming in-
fection•. Dameahek and Ingall, (19) in their review of 
aoo oases in 1931, found that most authors believed that 
the blood picture was due to a marked effect on the mye-
loid cells by a septic or toxic process the nature of 
which.was unknown. They stated that Stocke concluded that 
there are imperceptible transitions from pure or typical 
agranulocytosis .to the ~~ course of sepsis with rather 
an unusual type of leukopenia, and that agranulocytosis 
was not a special disease, but an abnormal reaction to 
sepsis. 
With the prevalent belief that agranulooytosis was 
' 
caused by an infection or septic process, it is not sur-
prising to find the reports of many men describing their . 
attempts to reproduce the disease by injecting into 
animals organisms isolated from lesions, from the bone 
marrow and from the blood stream of patients suffering 
o~ de~ from the disease. Lovett•s (76) work, in 1924, 
of injecting Pyocyaneous bacilli into guinea-pigs and 
causing a reduction of the leukocytes was the first work 
of this type attempted. In 1928, Dasse (31) reported a 
oaee in which throat cultures gave an almost pure culture 
of Bacillus pyocyaneoua. He made injections of living 
cultures of this organism subcutaneously into guinea-pigs 
and produced a slight reduction in the white blood oount 
and 1 alwaya a relative reduction of the granulooytes from 
68 to 30 per cent•. Kracke, (66) in 1933, expressed 
doubt in the results of Lovett 1s experiments. He felt 
that the granulopenia she produced was not below that 
which can often be observed in normal guinea-pigs. He 
isolated the Bacillus pyooyaneus from the blood stream 
in a patient dying from agranulocytosis but was not able 
to 1 disturb the blood picture• in rats and guinea-pigs 
with the bacteria. He said to his knowledge that •no 
one has been able to•. 'However,• be added, 1 '1'his does 
not mean that it should be ruled out as a possible caus-
ative factor.• Kracke tried various organisms with no 
success and believed others had all failed. He stated 
that bis results and those of others were •further 
18 
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evidenoe that some other type of toxic agent depresses 
the bone marrow, resulting in a.u overwhelming infection 
by any or every organism that happens to be residing in 
the gastrointestinal tract•. He did not attach etiolog-
ical importance to pathogenic spirillium,which had been 
thought a factor in the disease due to the fact that a 
large number of reported cases had a history of being 
treated for Vincent's angina,but dismissed this point by 
saying that the mouth infection occurs because of a low-
ered cellular resistance of chronic granulopenia, or be-
cause of an unrecognized attack of acute granulopenia. 
Kracke has been unable to discover and spirillium in 
autopsy or biopsy studies under dark field. 
Fried and Dameshek, {38) in their experimental work 
of producing neutropenia, infected rabbits with Salmonella 
suipestifer by way of the blood stream. By injecting 
small doses or overwhelming doses they could produce two 
types: l. Cases in which the animals recovered;:·a. t\11.llinat-
ing oases ending fatally. The blood picture showed leukopenia 
and neutropenia. In the oases in which recovery occurred 
the bone marrow showed areas of necrosis with patches of 
proliferation. In the fulminating cases there was but 
little evidence of myeloid proliferation. These workers 
concluded: 1 The results have shown that there are close 
similarities between the agranulocytoaia resulting from 
Hematogenous infection ·of rabbi ts with Salmonella: 
suipestifer and that observed in oases of agranulocytic 
angina in man. 11 
Dennis (24) approached the problem from a slightly 
different angle in a group of experiments carried out 
to teat the hypotheaia that leucocidin producing organ-
isms (Staphylococcus aureus, Streptococcus hemolyticua, 
Streptococcus viridana, and Paeudomonaa aeruginoaa) re-
strained from active invasion of the tissues, but so 
situated that their diffusible toxic products could be 
absorbed, were capable of producing granulopenia. The 
experiments were performed by inserting a "diffusion 
capsule", containing a serum broth culture of the organ-
ism to be studied, into the peritoneal cavity of a rabb-
it. In this way, he hoped to prevent any local tissue 
reactions to the organisms but hoped to cause an absorp-
tion of their toxic products. He found that Staphylo-
coccus aureus, Streptococcus hemolytious and a species 
of Proteus each produced a •more or leas chronic granu-
locytopenia• which terminated w1 th a fatal infecti·on by 
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a different bacterial species. Streptococcus viridane 
showed surprising virulence, producing an acute leuko-
penia within a few hours. Dennis believed that the pic-
ture produced in rabbits by Streptococcus viridans toxin 
was •analogous with that of acute agranulooytosis in man•. 
21 
His concept of the usual origin of the clinical agranulo-
oytio syndrome is that there is a •primary focus of in-
fection by one of the leucooidin-producing organisms from 
which leucocidin is diffused into the blood stream where 
it affects the neutrophils, and if present in sufficient 
quantities and toxicity it injures the granulopoietic 
elements of the bond marrow.u He thus suggested that 
agranulocytosis in man is due to the action of leucooid-
in, rather than to a specific microorganism. This work 
was not confirmed by Meyer and Thewlis (81), however, who 
attempted also to show that encapsulated pyogenic bacteria, 
acting as a focus, produce granulopenia. They used the 
same procedure that Dennis used and did produce an acute 
leukopenia and death of a rabbit in 40 hours but they 
found no •significant decrease in the per centage of 
neutrophils in the blood1 • 
Harrie and Schattenberg (44) in 1935, studied the 
effect on experiimental animals of the subcutaneous, 
intraperitoneal and intracardiac injection of B. enter-
itidis, B. welchi, and Streptococcus hemolyticus and 
the toxic products derived from these bacteria. The 
toxic material was prepared from the exudate obtained 
from guinea-pigs with fatal peritonitis which was in-
duced by these organisms and was then passed through a 
Berkefeld or Seitz-~z filter. When this filtrate 
was injected parenterally into guinea-pigs, •granulo-
penia was induced". These workers concluded that there 
was some doubt as to whether the condition they produced 
was a true reproduction of the human disease, and also 
that their experiments indicated to them that agranul-
ocytosis was due to varied causes. In 1936, Isaacs and 
his co-workers (51) stated "Despite various attempts it 
cannot be said that it is possible to produce tnue 
agranulocytosis in animals. This is not surprising if it 
is agreed that the condition occurs only in certain 
persons Who are susceptible. 
The idea that agranulocytosis was caused by a septic 
agent =a:a met with considerable Ol:iticisms from many of 
the men interested in the subject who felt that the 
septic aspects of the condition were only secondary and 
not of importance etiolcgically. Vos and Staal (126) in 
reporting a case concluded that agranulocytosis was due 
to a lesion involving, exclusively, the leukopoietic 
function of the bone marrow and that the "gangrene and 
sepsis are secondary and the role of the tonsils is 
without importance in the etiology•. Werner Schultz 
(109) in 1927, in reporting a case of "atypical tonsil-
itis • which he believed was actually agranulocytosis, 
stated that the toneilitis appeared late which "speaks 
for the theory that the tonsil is only a point of 
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localization of the disease, not the portal of entrance". 
Hueper stated, in 1928, (49) that the demonstration of 
bacteria in the blood of patients with agranulocytos1s 
•1s not proof of the infectious character of the disease 
because bacteria are also frequently found in later 
stages of leukemias and their presence is due to invasion 
of the body through the a~eaa of necrosis•. .Also in 
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1928, Dayton (23) stated "The necrotic condition of the 
mouth and throat and other mucous membranes is secondary 
~o the agranulocytosis and due to the absence of the 
defensive posers of the leukocytes, since it is commonly 
found when this condition is present, regardless of the 
nature of the causative agent.• Rosenthal (103) conclud-
ed in his observations, in 1930, that the septic manifest-
ations •are of a secondary nature and produce pathologic-
al lesions which are Q,ommon to s'ptic coildi tione without 
the inflammatory reaction•. 
It remained far Roberts and Kracke (99) in 1930 to 
offer definite clinical proof that the septic manifest-
ations were of secoIXiary importance in the disease. 
·They reported in that yea:r a case of a 72 year old woman 
who survived a first attack of agranulocytosie. Following 
her recovery she was confined to the hospital for obser-
vation. Daily blood counts were made although she was 
clinically well. Two months following her first attack 
it was noticed that there was a sudden drop in the leu-
,...,..., . 
24 
kooyt·e count and that the polymorphonuclears entirely 
disappeared. The patient was clinically well even then, 
but on the fourth day following the first change ~b the 
blood picture she became-~ acutely ill with typical 
symptoms and signs of agranulocytosis and died three days 
later. From their observation of this case Roberts and 
Kracke offered the followi~ as an explanation of the 
mechanism involved in the production of the disease: 
"The bond marrow before the clinical onset had ceased to 
manufacture granulo'cytes. 'l'he marrow evidently passes 
through a period of dysfunction to complete &function 
in a case presenting total absence of the polymorpho-
m:lears. But the primary lesipn, the primary dysfunct-
ion, the primary afunction is in the myelocytic divis-
ion of the marrow even before the clinical onset. The 
disease exists in the bone marrow before it appears in 
the blood stream and in the blood stream before it ap-
pears clinically.• In 1931, Iraoke (65) made similar 
observations in a case of a 44 year old woman lib. o had 
recurrent acute.attacks of agranulocytosis interspersed 
with prolonged periods of chronic granulopenia. By re-
corded blood counts during the periods of chronic 
granulopenia he again observed that the onset in the 
bone marrow preceded the appearance of clinical symptoms. 
In another paper wr~ t_ten in 1932, Kracke ( 66) stated.: 
1 I believe it can be reasonable assumed that agranulocy-
tosis is primarily a disease of the myeloblastic tiss-
ues, followed by loss of resistance resulting in over-
whelming infection.• In the same paper he appeared, how-
ever, to attach some etiological importance to infection. 
He stated that it might be possible that the bone marrow 
depression was caused by 'hidden or latent infection over 
a long period. 1 , so that when the •resistance fell to a 
low ebb 0 , acute infection followed because the myelocytio 
tissues.were "unable to meet the emergency• He felt that 
the number of cases he had seen following influenz~ after 
a variable length of time added support to this view. He 
said, "Since the infecttng agent of influenza tends to 
produce a leukopenia, it is quite possible that the resid-
uals of the 1nf ection produce a slow and gradual damage 
to the bone marrow from which it is unable to recover•. 
In 1928, Heuper and O'Oonnor (50) wrote, 1 The infectious 
origin and character of the disease as asserted by numer-
ous authors seems to us not proven. The presence of 
streptococci or other bacteria in the blood is not con-
sidered by us as a primary condition, but as a secondary 
one due to an invasion of these bacteria through the 
necroses in the mouth•. They believed that all cases 
reported as agranulooytosis which developed this symptom 
complex following "a purulent infection and showing 
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evidence of suppuration, generalized hemorrhagic diathesis, 
secondary anemia, myelocytie reaQtion in the blood and 
bond marrow• could not be recognized as •essential• agranu-
locytosis but were •probably more correctly classified 
as septic infections with an agranulocytic symptom complex• 
which are also observed in man other diseases, as aleukemio 
leukemia, pernicious anemia, oarcinosis or the bone and 
abdominal lymphogranulomatosis. 
The oase reported by Rutledge and his co-workers (105) 
of a patient showing periodic neutropenia tends to elimi-
nate the hypothesis that agranulocytosis is due to a septic 
process acting on the myeloid tissue. Th~ir case was one 
in which cyclic, agranulooytio angina associated with fever 
and constitutional symptoms, but without anemia, began at 
the age of two and one-half years and recurred at intervals 
of approximately three •eeks, during the entire life of a 
man ao years of age. Th._is case is apparently unique in 
medical literature. This is the· same case reported by 
Leale (72) in 1910 as •Recurrent rurunculosis in an Infant 
Showing an Unusual Blood Picture• and was described earlier 
in this paper in the History. Case number three in Doan•s 
(65) series also showed a periodic recurrence. 
Hyperergic Inflammation.--A few authors believe that 
agranulocytosis may be a form of hyperergic inflammation 
(allergy) in which the bone marrow is the point of least 
resistance. Schilling (107) has produced a blood picture 
similar to agranulocytosis experimentally in a.naphylaxis 
so that he thinks it may be an anaphylactic condition 
instead of an individual disease. In as review of agranu-
locytosis in 1931, Pepper (89) stated: •studying the cases 
I have seen for some common factor, I have been struck by 
the presence of allergy in each. This may, of course, be 
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a mere coincidence, but this is unlikely for allergy occurs 
in only ten per cent of the race. I am sufficiently im-
pressed by the evidence to suggest that a.granulocytic 
angina may have allergy as the background.• In 1929, 
Bromberg and Murphy observed a fatal case of agranulooy-
tosie following prophylactic typhoid vaccination. They 
stated that the abnormal reaction of the hematopoietic 
system occurred so directly after the injections that it 
suggested that they •may have been the toxic agent that 
incited the clinical manifestations' of agranulocytosis. 
Kracke (65) reported a case 1n 1931 in which a woman failed 
to recover from the final dose of typhoid vaccine inno-
oulation. She remained in bed with daily fever and extreme 
weakness for thirty days, culminating in three attacks of 
agranulocytosis. Kracke said: 8 The question of typhoid 
prophylaxis as a whole or partial ca.use of the condition 
must be eonsidered. 0 Beck (3) brought out the fact that 
inactivated typhoid bacilli have a marked ohemotaotio effect 
,,,,,,.... 
on the bone marrow. She stated that a few of the cases had 
shown eosinophilia in further support of the theory of 
anaphylaxis, but she added that these cases may have re-
sulted from an overwhe1ming reaction to foreign protein 
in a sensitive subject. 
Congenital and Familial Bone Karrow Inadequacy.-- A 
familial tendency to diseases of the hematopoietio tissues 
of one type or another presents another possibility in the 
etiology of agranulocytosis. Hart (45) 1 in 1927, suggested 
a familial tendency when he observed agranulocytosis in two 
sisters age 32 and 42. Harkins (43) reviewed 150 oases 
from the literature, in 1931, and ma.de this statement: 
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•one element in agranulocytio angina may be a constitutional 
defect of the bone marrow.• Rosenthal (103), in 1930, from 
the fifteen cases he had observed and·the others he had 
reviewed, concluded that he was inclined to the idea that 
agranulooytosis was a clinical entity, •related in some 
instances to a constitutional hypoplasia of the leukopoietic 
system; in other oases it may be a result of transitory 
hypoplasia• •. Beck (3) stated that congenital. granulopoie-
tic insufficiency seemed to have been proved in sane Qases, 
but that the granulopoietic tissue in most of these patients 
had, so far as was known, functioned normally for many years. 
The cyclic and recurring nature, mentioned previously, of 
some of the cases is ha.rd to explain on the basis of a. con-
genital lesion. Blumer (8) dismissed the possibility of 
a congenital anomaly with the following statement: "The 
same patient has reacted with the usual leukooytosis and 
granulcytosis to one attack of an infection and has shown 
a neutropenic and leukopenic reaction to another attack.• 
Beck (3) concluded: 11hether certain patients have a con-
s,i tutional and abnormal functionally limited bone marrow 
for making blood is as yet a theoretical 'IUestion. 1 
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Endoc~ine Disturbances.-- The possible etiological im-
portance of an endocrine disturbance in agranulooytosis was 
suggested by Thompson (134) in 1934. This author made a 
study of forty cases of the disease and found that in seven-
teen out of eighteen women, the onset of the subjective sym-
ptoms of agranulocytosis occurred within one or two days of 
the menstl'U&l period. In six of those patients, one or more 
recurrences were seen, each appearing at the same time as 
oatamenia. Two patients who had had attacta previously were 
followed with blood counts through a menstrual period and 
a definite neutropenia occurred without subjective symptoms 
a few days before cata.menia. Thus, it seemed possible to 
Thompson that in some cases of agranulocytosis, there was a 
relationship between the hormones associated with menstrua-
tion and the neutropenio episodes. In the same year, Jack-
son (57) and ~is oo-workers reported the case of a women, 
age 30, who bad four typical attacks of agranulocytosis in 
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two preceding years. Her relapses had occurred in each 
case with the onset of each menstrual period. Oloae obser-
vation of the blood picture revealed that with the onset of 
each menstrual period, the total number of polymorphonu-
clear neutrophils fell precipitantly, only to rise again.to 
approximately the previous level. With each oatamenia the 
fall in the count became greater and subsequent recovery 
less satisfactory. The authors felt that there was a de-
finite •temporal relationship• between the menstrual cycle 
and the intensity of the leukopenia. It is interesting to 
note that a different possible endocrine relationship was 
observed by Oorey and Britton, in 1932, (17) in their study 
of the blood cellular changes in adrenal insuf~ietency. 
They found that an agranulopenic syndrome was produced in 
adrenaleotomized cats. Hubble (48) suggested that glandular 
dysfunction may play a role in producing the disease and · 
stated that bone marrow depression might be caused by a 
pituitary insufficiency or granulopenia by cortical dys-
function. Baldridge and Needles (2) were also of the opin-
ion that endocrine disturbance might possibly have a causal 
relationship to agranulocytos1s. Generally speaking, however, 
the great volume of medical literature on this disease pro-
duces little evidence that endocrines are of primary import-
ance in the etiology. 
Itiologio Importance of Drug Therapy.-- Chemical pois-
oning of the hematopoietic system is well known, but usually 
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drugs do not have an affinity for just the granulopoiet1c 
tissue. Farley (32) reviewed from the literature, in 1930, 
thirty-nine oases in which the function of the bone marrow 
was depressed following the use of various preparations of 
arsphenamine. The symptoms varied from those of purpura 
hemorrhagic& to those of severe aplastio anemia and agranu-
locytosis, depending on whether the principal effect was on 
the granulopoietic, megaltaryopoietic or erythropoietic tiss-
ues, or on all of these combined. In 1931, R. R. Kracke (65) 
made the first observation of the possible relationship be-
tween agran~looytosis and drugs containing the benzene ring. 
He reported the case of a 44 year old woman who gave a his-
tory of using large amounts of coal tar derivatives during 
the previous three years. He said: 8 8inoe it is known 
that benzene is a powerful leukocyte depressant, and that 
coa.l tar derivatives are for the most part altered benzene 
rings, the possible association should be considered.• He 
added, significantly, that coal tar derivatives have had 
their widest usage since the world war. Dodd and Wilkinson 
(29) showed, in 1938, that arsenioals would depress the 
leukocyte count. Talley and Griffith (122), in 1930, re-
ported one of the few cases of agranulocytosis that have 
been reported in negroes as following araphenamine. Kracke, 
(. :(96), in 1932, admitted that arsenioal preparations 
should be considered as possible etiological factors until 
definitely ruled out. He stated that Benzene, however, 
was the only chemical that has been shown for many yea.rs 
to be capable of producing a marked depression of the 
leukocyte count to the point of complete agranulocytosis. 
He stated; •Therefore it is the outstanding agent that 
should be considered as causative of agranulooytoeis.• 
(66) 
Kracke/found that one of the first observations of 
the toxic effect of benzene on the myeloblastic tissues 
was that of Selling, i~ 1910, who observed three young 
girls who had been working in a rubber factory where 
they had been exposed to benzene fumes and then entered 
Johns· Hopkins Hospital. w~th a clinical picture similar 
to agranulocytosis complicated by purpura and hemorr-
hages. Two of these patients died and the bone marrow 
was found to be hypopl'astio. The interesting features 
of these cases W!l1'8 the early ohronioity of snaptoms, 
followed by sudden loss of neutrophils and rapid death. 
One of .the patients had long before quit her work, which 
could be interpreted as illustrative of the cumulative 
and delayed effect of the chemicals on the hematopietic 
tissues. Selling (112) followed this observation by ex-
perimental studies on rabbits. He injected benzene sub-
cutaneously in rabbits and succeeded in producing a 
leukopenia down to 200 cells per cubic millimewer. He 
concluded that benzene destroyed white cells of the oir-
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culating blood and •parenchymal cells of the hemato-
poietio system", but that the circulating erythrocytes 
were little affected. Winternitz and Hirschfelder 
(130) showed that a pneumonia exudate in benzene treat-
ed rabbits contained erythrocytes, fibrin, and endo-
thelial cells but not neutrophiles. Hektoen in 1916, 
(46) concluded that resistance of benzene treated 
animals was decreased by loss of neutrophiles, "Reduction 
in antibodies and reduction in phagocytic activity of 
leukocytes present•. His experiments appeared to bear 
this out. Weiskotten and his associates, (129) in their 
experiments to determine the normal life span of the 
neutrophile in a rabbit, did a great amount of work on 
the action of benzene in the animal organism. They 
showed that benzene produced an aplasia of the myelocytic 
tissues, a marked granulopenia, and that the life span of 
the rabbit neutrophile was about four days. From these 
reports it seems that the ability of benzene to produce 
a reduction of neutrophiles with resulting death has been 
well demonstrated in both man and expertmental animals. 
There are those, however, who believe that the 
picture presented by benzene poisoning and that presented 
by agranulocytosis is not the same. Beck (3) states 
that benzene usually does not produce typical agranulo-
cytosis, but a depression of all the bone marrow elements, 
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so that anemia, purpura and sometimes methemoglobinemia, 
as well as leukopenia and neutropenia, ane produced. 
However, Kracke, (66) was of the opinion that the chief 
action of benzene was on the myeloblastissues, and that 
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it could be administered in such dosage to produce marked 
granulopenia with no apparent effects on either the 
erythrocytes or platelets. Therefore, in 1932, be conduct-
ed a group of experiments to prove his point, with the fol-
lowing conclusions: (1) Subcutaneous injections of ben-
zene and olive oil, if given in sufficient small doses, so 
as not to affect the erythroblastic tia~ues, resulted in 
the development of clinical agranulocytosis. The smaller 
the dose, the more selective became the affinity for the 
myelocytio tissues. (a) The intravenous injection of ben-
zene even in small doses resulted in the immediate death 
of the animal, "so it is probable that oxidation products 
of benzene are directly responsible for its leukocyte 
depressing properties•. A marked leukopenia was produced 
by the subcutaneous injection of ortho-exybenzoic acid 
and by the intravenous injection of hydro-quinone. (oxida-
tion products.) (3) He was unable to depress the leukocyte 
count in animals with: aminophrine, phenacetine, peragla, 
dial;; resoroinol, pllrocatechin, orthocresol, metacresol, 
paraoresol, phenol, pa.ra-oxybenzoic acid, meta-oxybenzoio 
acid, or 50 per cent alcohol. J'ollowing theae experiments, 
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Iraoke concluded: 11 The etiology of agranulocytosis is 
unknown but the benzene ring must be strongly considered.• 
In the same paper, he reported that eight of the nine 
patients w1 th agranulocytosis that he had seen had taken 
drugs of the coal tar series prior to the onset of their 
illness. rollowing this report by Kracke, interest in 
agranulocytosia soon began to center about the role of 
certain drugs as etiologic factors in the causation of 
the disease. 
In October of 1935, Madison and Squier (77) reported 
before the Central Society of Clinical Research that 8 the 
increased incidence of primary granulocytopenia has para-
lleled the increase in use of drugs containing a barbitur-
ate combined with amidopyrine•. In a later article, (78) 
these same authors reported that in 1931 they observed a 
case which suddenly took a turn to the worse w1 th abrupt 
decrease in granulocytes. They found that the patient had. 
been given a sedative dose of a barbituric acid derivative 
on the preceding evening. The drug was withdrawn and not 
repeated and the patient recovered. !hey later discovered , 
that immediately before the onset of the illness, the 
patient had taken allonal (allyisopropyl barbituric acid 
with amidopyrine) and for some time previously had been in 
the bavit'of taking that drug frequently. Soon after they 
saw a woman who had had acute cholecystitis and was treated 
by rest, diet, and two allonal tablets each nite for a 
period of two weeks. At the end of that time blood examina-
tion revealed the presence of only 1,200 white blood cells 
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with a complete absence of granulocytes •. It was thee two 
oases that so emphasized in the minds of lladison and lquier 
the importance of drugs in this disease that they studied 
the relationship in all oases seen subsequently. Since 
these two oases, thes authors reported, in 1934, that they 
had treated twelve more. In each of the fourteen oases 
there was a definite history of the taking of amidopyrine 
in combination with a barbiturate, amidopyrine alone, or 
in one instance in combination with other drugs, immediate-
ly prior to the clinical discovery of the agranulocytosis. 
Amidopyrine w~th a barbiturate had been used in seven of 
the cases, amidopyrine alone in six, and a.midopyrine in 
combination with other drugs in one. They stated: 1 The 
mortality in a group of six patients who continued the use 
of drugs containing amidopyrine was one hundred per cent. 
In a group of eight patients who did not continue the use 
of these drugs, only two died, and both of these in the 
initial attack.• To obtain further evidence of the ability 
of these drugs to depress the granulocytic tissue,. drugs 
suspected of etiologic relationship were given to each of. 
two patients who had clinically recovered from acute agranu-
locytosis. The first patient, a man aged 40, who eighteen 
months previously had had his initial attack following the 
use of allonal and who had had a normal granulocyte count 
for ten months, was given five grains of &$idopyrine. In 
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three hours he had a chill with return of symptoms of the 
acute illness and in twelve hours the granulocytes had al-
most completely die~ppeared from the peripheral blood. The 
second patient, a women, responded ~1th similar results 
after the administration of amytal and amidopyrine;. Amytal 
alone was tried in the latter case but failed to produce the 
effect. Unaware of ~aoke's (66) experiments with these 
drugs on rabbits, lladison and Squier (78) attempted similar 
ones. One rabbit was given allonal by mouth in relativel1 
large doses. There was an abrupt drop in granulocytes and 
the rabbit died on the thirtieth day. Preceding death 
there was complete absence of granulocytes in the peripher-
al. blood. Seventeen other rabbits were given allonal or 
amidopyrine~~ but they failed to show any marked change in 
the blood picture. These authors, therefore, concluded: 
•we believe that, am1dopyr1nealone or in combination with 
a barbttutio acid is capable of producing primary granu-
locytopenia in certain individuals who have developed 
sensitivity to the drug. We believe that the appearance 
of primary granulooytopenia f ollo1fing the use of such drugs 
may be the result of an allergic or anaphylactoid drug re-
action.• 
In 1934, Kracke and Parker (68) stated that they 
found agranulooytosis was more prevalent among physicians 
and thetr relatives, nurses, hospital employees, and 
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members of allied professions, than in any other group in the 
United States. The fact that such drugs as amidopyrine 
was especially available to this group seemed especially 
significant to these writers. In the same paper, they 
presented eleven cases in which the patients were addicted 
to the use of prescriptions or tablets containing amidopy-
rine (peralga tablets), phenacetine, acetanilid, aspirin, 
eaffiene, empirin compound, allonal, or pyramidon. Rawls, 
(95) in 1934, stated that amidopyrine had been used exten-
sively in the arthritis clinic of the New York Polyclinic 
Kedical School and Hospital. Two patients in this clinin 
developed neutropenia while taking the drug. One case was 
fatal The other patient returned to normal nine days after 
amidopyrine was omitted, without any other form of treat-
ment. After a period of rest the drug was resumed and the 
neutropenia recurred. ~his time pentnucleotide therapy 
and omission of the amidopyrine brought the blood to normal 
in eight days. 
Watkins (128), at the Kayo Clinic, reported 32 cases 
of agranulocytosis. Twenty-four of his patients had taken 
ami.dopyrine or barbital derivatives. Watkins concluded: 
•1 do not feel that these cases prove that amidopyrine, or 
derivatives of barbituric acid are etiologic factors in 
producing agranulocytosis, but I do tielieve that there is 
a possibility that certain individuals have an 1d1osyncracy 
to the drugs, which is manifested by agranulocytosis. 
Randall (94) reported in 1934 the case of a twenty-
five year old woman house physician who developed an 
aoute and alarming leukopenia·following the use of 
barbiturates and amidopyrine 1may therefore occur only 
in those individuals who are unusually susceptible to 
the benzene chain. 1 Hoffman and his associates (47) 
reported that in twelve of their fourteen cases of' 
agranulocytosis a history was obtained of the taking 
of some form of amidopyrine. Thirteen of their cases 
were fatal. They explained that the common factor in 
amidopyrine, benzene, arsphenamine, dinitrophenol, ortho-
oxybenzoic acid, and hydroquinone, 11 all of which have 
produced neutropenia experimentally or clinically,• is the 
benzene ring. "Whether", they wrote, 11 The latter is the 
actual toxic agent in the production of neutropenia needs 
further experimentation. Our work points to amidopyrine 
as having a definite effect on myeloblastic tissue similar 
in man and rabbits.• They gave rabbits doses of amidopy-
rine, a.a to 0.9 grams per kilogram, by mouth. An almost 
immediate leukocytosis occurred which was followed by a 
depression of the white cell count. In some of the rabbits 
the polymorphonuclears were as low as eight per cent and 
in all they were twenty per cent or under. 
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The fact that a person ingests a certain drug immediately 
before the onset of a disease is sugge.stive but not con-
clusive evidence that it is the cause of the condition. 
The strongest evidence of this view, however, lies in such 
cases as those reported by Kadison and Squier (78), Sturgis 
and Isaacs (120), and Plum (92) who produced leukopenia in 
patients who had. recovered from agranulocytosis promptly 
after small doses of amidopyrine were administered~ 
The relationship between amidophyrine and agranulocy-
tosis has been studied by the Council on Pharmacy and 
Chemistry of the American Medical Association (98) with 
the conclusion that •as far as can be learned from the 
evidence at band there can be no question that amidopyrine 
is very important in the production of granulocytopenia. 
It appears that barbiturates alone have little or nothing 
to do with the condition.• They advised, 1 Tbe indiscrimi-
nate and unnecessary administration of amidopyrine, and 
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the self administration by the public is certainly danger-
ous and should be discouraged.• Plum (92) reviewed com-
prehensively the relatinn of amidopyrine to agranulocytosis 
and stated, in 1935, that in a yea:r and one-half 128 cases 
had been reported in which the disease developed after 
therapeutic doses of amidpyrine. Sturgis (121) emphasized 
that this drug is not the sole cause of the condition and 
Jackson (56), in 1934, reported a whole series of cases in 
which there was definitely no history of such therapy. Of 
course it is possible that in some of the oases in which 
the patient reported that he had not taken amidopyrine as 
such, he may have ta.ken it in combination with a barbi-
turate or some other drug under a trade name. 
Kracke and Parker (69) wrote in 1935 a very compre-
hensive article on the etiology of agranulocytosis and 
concluded that a great deal of evidence had been accumu-
lated which indicated that the administraction aminopyrine 
alone or in combination with one of the barbiturates was 
responsible for the disease in a large number of patients. 
They emphasized that it is almost impossible to obtain an 
accurate history as to the ingestion of drugs after a 
patient is dead. They cited examples which illust~ate how 
difficult it may be to secure a reliable history even from 
a living patient and concluded that a •negative drug his-
tory is a worthless one." 
In his paper in 1935, Gordon (41) was not in accord 
with the more prevalent view that aminopyrine was an im-
portant factor in the production of agranulocytosis. Af-
ter questioning 59 patients, he concluded that in only one 
case could any therapeutic agent have related to the etio-
logy of the disease. In his opinion a number of factors 
may be responsible for the disease, but he considered that 
its absolute etiology still had not been recorded in the 
literature. Jackson (54),in 1935, wrote that aminopyrine 
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had an important etiologic significance in some cases, 
but he expressed the opinion that conclusive evidence 
had not demonstrated that it was the sole or even the 
major cause of the disease. In urging that caution be 
used in accepting this drug as an important cause of the 
agranulocytic state, he stated, in regard to its etio-
logic relationship to the disease, that some pat·ients re-
cover even though the a.minopyriµe therapy is continued; 
and that in other patients there was no evidence to in-
dicate that the drug was taken prior to the attack. He 
has observed patients who took aminopyrine and became ill 
with the disease, but despite the fact that the drug was 
discontinued one or more relapses occurred. In other pa-
tients, in whom the attack was precipitated by aminopyrine, 
there had been no evidence that after recovery they con-
tinued to be sensitive to it. He stated that it had been 
suggested that the incidence of the disease was becoming 
less, and that this had been attributed to the withdrawal 
of the drug from the market, and yet he found that ·the 
sales of aminopyrine had actually increased in the six 
months prior to the time his paper was written. 
Squier and Madison's (116) article, in 1935, pre-
sented observation on two patients which showed the effect 
on the granulocytes in the peripheral blood of ·ten grains 
of amytal compound (amytal with aminopyrine), five grains 
of a.minopyrine alone, and the application of a ten per 
oent solution of the latter drug to the unbroken skin. 
A significant granulopenia developed following the ad-
ministration of the foregoing drugs, but there was no 
important change in the white blood cell count when amytal 
alone was given. They concluded that.the oause of the 
disease was an •allergic response to certain drugs• rather 
than a 1 heightened pharmaceutic or physiologic response.• 
Iastlin (63) bas made the observation that there must be 
a variability of susceptibility in "sensitive• persons if 
aminopyrine plays an important etiologic role in this 
disease. He reported the case of a patient who bad taken 
this drug for years on account of insomnia. A marked 
granulopenia developed (800 white blood cells per oubic 
millimeter), but reoovery followed despite the daily ad-
ministration of amytaJ. and aminopyrine and of an allyli-
sopropyl barbituric acid with aminopyrine. The granulo-
penia reourred, however, and the drugs were withheld. 
After a temporary recovery the disease again progressed 
and terminated fatally. 
Limarzi and Kurphy (73) reported a case, in 1935, of 
a young woman, age 24, who had four recurring attaoks of 
agranulocytosis over a period of about two a.nd one-half 
years. She had taken from fifteen to twenty grains of 
aminopyrine, with or without aoetylsalicylio aoid, each 
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week for the previous four years and yet showed no clini-
cal evidence of agranulocytosis in the interim between the 
attacks. furthermore, during the last attack, at.which 
time the leukocyte count fell to 1700 per cubic milli-
meter, with twelve per cent polymorphonuclear neutro~hils, 
a total of 370 grains of aminpyrine was given. Despite 
I 
this, the blood returned to normal, and the patient made 
44 
a complete recovery. 0n the basis of this case, these 
writers believe a patient •may become specifically sus-
ceptible from which a selective toxic action on the bone 
marrow may arise.• They made a skin patch test in this 
case, but it was found to be negative. 
Stenn (117), in 1935, was unable to produce the di-
sease in guinea-pigs, rabbits or monkeys when aminopyrine 
was given orally, subcutaneously, intraperitoneally and 
intravenously. He also was unable to produce the disease 
when the drug was injected into animals in which an attempt 
had been ma.de to sensitize them to it. He used a total 
of 120 animals in his experiments and concluded that there 
was no evidence that agranulocytosis could be produced in 
animals by aminopyrine under the following circumstances: 
(1) 'I.hen there was severe anemia as a result of bleeding; 
(2) after the 1 bone marrow had been previously injured by 
the administraotion of benzene and olive oil 1 ; after the 
animals had been infected for one m,nth with Bacillus 
subtilis, Streptococcus viridans, and Salmonella sui-
pestifer, and (4) after a complete fast of five days. 
Similarly, Kunde and his co-workers, (70) in the same 
year, were unable to diminish the number leukocytes 
in the circulating blood of normal rabbits by the ad-
ministration of Oibalgine (aminopyrine and diallyl mal-
onyl urea) orally in large doses for seventeen consecu-
tive days. They also studied the effect of this drug on 
rabbi ts with 11 sniffles" or a 11 certain gastro-intestinal 
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inf ection11 inwhcih there is normally a marked leukooyto-
sis. This leukocytosis was not depressed by administra-
tion of the drug for seventeen to thirty days. Smith and 
Ma.ck {115) likewise were unable to produce a.granulocytosis 
although they did produce some degree of leukopenia in e5-
perimenta.l animals. Working on the )ypothesis that a de-
ficient diet plus the toxic effect of drugs was of possible 
etiologic importance, these men tested the action of amytal 
and a.midopyrine on the blood picture of twenty-six, sixty 
day old albino rats weakened by a deficient diet. They . 
found that the white blood count was reduced approximately 
fifty per cent but that the differential counts showed no 
significmt reduction of granulocytes. A control grcup of 
rats received the same deficient diet but no drugs and 
their blood showed no change in the white cell count. 
Climenko (16) , in 1935, s~udied the inhibiting 
effect of aminopyrine, antipyrine, alpha-dinitrophenol, 
phenylhydrazine hydrochloride, catechol and orthoquinone 
on the leultocytosis which is ordinarily produced in the 
rabbit by the parenteral injection of nucleic acid. He 
found that the intramuscular injection of five milligrams 
of nucleic acid per kilogram of body weight produced a 
maximum white blood cell count of 15,000 in four hours, 
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34 per cent of the cells being polymorphonuclear neutrophils. 
After the rabbit had received 0.2 grams of aminopyrine oral-
ly for eighteen days, a similar dose of nucleic acid was 
given intramuscularly. No .significant response was evoked 
in the white blood cell count. 'lbe other drugs mentioned 
produced atmilar inhibitions to leukooytosis. 
The theory that aminopyrine may be responsible for 
agranulocytosis in certain susceptible persons has received 
fairly widespread acceptance. It is known, however, that 
many persons may take large amounts of the drug without 
producing the syndrome. Nor can it be said that it is the 
sole etiologic agent, as other drugs, such as dinitrophenol, 
apparently have been responsible for its production in some 
instances. In 1934, .Hoffman and his associates (47) report-
ed the first case of dinitrophenol causing agranulocytosis 
in a patient who had taken the drug for ~eduction purposes 
for a period of two weeks. She recovered. Bohn, (10) in 
the .same year, described a case which deviloped in a pa-
tient after the ingestion of 21.8 grams of dinitrophenol 
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sodium over a period of four months. Dameahek and Gar-
gill (18) reported two cases of agranulocytosis following 
the use of dinitrophenol therapy. 
Although all observers are not in accord, Rawls (95) 
olained, in 1936, that sufficient data have been accumulated 
to indicate that aminopyrine bears some causal relation-
ship to agranulooytosis. He administered over 100,000 
tablets of aminopyrine or aminopyrine mixed with magnesium 
carbonate to 400 patients in clinic or in private practice. 
In four (one per cent) of these patients agranulocytosia 
developed, and three died of it. Exclusive of the four 
patients, there were no significant changes in the white 
blood cell picture of 100 patients who received an average 
daily dose of about thirteen grains for a mean interval of 
approximately eighty-four days. Rawls concluded that 
aminopyrine does not produce hematologic changes •except in 
isolated oases, in which there probably is an idiosyncraoy 
to it.• 
The blood of one hundred patients with various diseases, 
chiefly rheumatism and infections of the upper respiratory 
tract, who were treated with salipyrine (combination of 
salicylic acid and antipyrine) was studied by Nammaok and 
Thorsteinson. (85) They explained that antipyrine contain-
ed a benzene ring and was closely related in chemical struc-
ture to aminopyrine. Their repeated examinations of the 
blood of the patients failed to show a significant change 
in the total white blood count or in the percentage of 
neutrophila, nor was there any change of importance in the 
Schilling count. From their experience and a review of the 
literature, the authors concluded: "Heutropenia in connec-
tion with drugs containing the benzene ring probably de-
pends on individual idiosynoraoy to this type of drug.• 
Witte (131), in 1936, aptly stated that the evidence 
incriminating aminopyrine as the chief cause of agranu-
looytosis may be classified as ciroumstantional, experi-
mental and direct. Circumstantional evidence includes the 
many reports in which a history of the taking of the drug 
prior to illness was obtained. Experimental evidence lies 
in the production of the disease in laboratory animals by 
the administration of aminopyrine. Direct evidence is found 
in those cases which have recovered from an attack thought 
due to the drug, and which another attack has been precipi-
tated by administration of the drug. Witt mentioned in 
the same paper that in England the 'Poisons List Confirma-
tion Order•, which went into force on May l, 1936, makes 
it necessary to have a written order before aminopyrine can 
be supplied. 
Parker and Kracke, (87) in attempting to produce the 
disease experimentally, cause leukopenia of •usually less 
than 1,000 leUkocytes " in rabbits by the subcutaneous in-
jection of benzene in olive oil and showed that these an-
imals had a marked depletion of the biologically active or 
-reduced glutathione in the bonemarrow and the blood. They 
suggested that a depletion of this form of glutathione in 
human blood and bone marrow may lead to various leukopenic 
states. 
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Benjamin and Biederman ( 4) reported observations on the 
blood of a patient after the oral administration of 10 
grains of Novaldin, a drug which is closely related to amino-
pyrine. This preparation was given to a woman who pre-
viously had had several attaek·s of agranulocytoeis after the 
ingestion of aminopyrine. Eight hours after the drug was 
given subjective symptoms appeared and within twenty-four 
hours the white cell count had fallen from 5,300 to 2,800 
and the polymorphonuclear neutrophil cells had been reduced 
from 73 to 46 per cent. Intraoutaneous, patch and passive 
transfer tests with Novaldin gave negative results. The 
authors concluded that this drug may "produce the same de-
leterious effects as aminopyrlne on the hematopoiet1c sys-
tem". Klumpp (64) substantiated this view •hen he reported 
the oases of a patient in whom agranulocytosis developed 
after the use of N0 valdin for headache. The patient expir-
ed after a fulminating illness of six days, during which 
time the leukocyte count fell to 150 with a complete ab-
sence of polymorphonuclears. In attempting to answer the 
question, "Is there a safe method for administration of 
aminopyrine and its derivatives?" Klump concluded, "The 
abrupt onset without warning and fulminating course of 
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this case, and others I have seen, lead inescapably to the 
same co clusion that there is o entirely safe method of ad-
minstering aminopyrine.• 
Goldman and Baber (39) reviewed the literature concern-
ing the relation between dinitrophenol and granulopenia and 
added the report of a.n a44ttional case which they had ob-
served. Their patient, a girl of 13 years, had taken 0.1 
grams of dinitrophenol daily for forty-six days. Wea~nese, 
malaise, feverishness, sore thorat and vomiting appeared and 
she suddenly became acutely 111: and irrational. The white 
blood cell count was ?00 with 100 per cent lymphocytes. The 
patient died and no changes were found in the granulopoietic 
system at autopsy. Goldman and Haber concluded in reference 
to this case: 1 The fatality can be attributed either to cumu-
lative toxicity or to an idiosynoracy to the drug. 0 
Davis and Friasel (aa), in 193?, reported that they had 
given aminopyrine daily to 'thirty-two patien1is for varying 
periods up to three months without demonstrating any altera-
tions inthe white blood cell count. They also observed 
patients who had used the drug for more than four years 
without dangerous clinical symptoms. Of fifty patients who 
received cutaneous teats with aminopyrine, only one, who 
was seuaitive to the drug, reacted positively. However, 
these writ.era did report that 1-n their aeries of twenty 
eases of agranulooytosis, ten of the patients were known 
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to aave ta.ken aminopyri~e or allied drugs. Shapiro and 
Lehman (113) reported that they observed a man in whom 
agranulocytosis developed after he had taken cinchophen, 
o.5 grams three times daily for about three weeks. They 
pointed out that cinchophen under "certain Conditions" aay 
yield benzene or nitrophenol, either of which "can cause 
a paralyzing effect on the bone marrow". Dowds (30) re-
ported a fatal oases of a granulocytosis in apatient with 
syphilis. He concluded that intramuscular injections of a 
bismuth preparation caused the condition, and he stated 
specifically that aminopyrine was not a contributing factor. 
Davis and Frissell (22) summarized the literature 
regarding aminopyrine hypersensitivity and found discussions 
of three theories to explain the role of aminopyrine i{ltoxi:-
oation in ~he production of granulocytopenia; 1. All drugs 
with the benzene nucleus, or the benzene nucleus in associa-
tion with an amino group, are per se toxic, presumably to 
the bone marrow. 2. Aminopyrine is semispecific for the bone 
marrow and produces a direct intoxication of the leukopoie-
tic tissue. 3. The hemopoietic changes are the result of an 
allergic reaction. 
Sulfanilamide, the remarkable drug which has proved to 
be of so much value in the treatment of beta streptococcus 
infections, gonorrhea, pneumonia, and other infections, is 
not without its dangers to the blood. These dangers include 
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the deve1opmant of methemoglobinemia and cyanosis, acute 
hemolytic anemia and now agranulocytosis. (67) In a letter 
written April 17, 1937, Plumer (93) described the case of 
a woman of 54, suffering from subacute bacterial endocardi-
tis of about five months duration. Her blood culture was 
positive for streptococcus virida.ns. She was given one gram 
of prontylin a day for four days, and 1.3 gra.me for thirty-
one days, when it was discontinued because of nausea and 
vomiting. 'l'hree days, thereafter, the white count had fallen 
to 400, with no neutrophils; it rose the next day to 1600, 
but extensive gangrenous infection of the mouth and pharynx 
had already developed and death occurred on that day. As 
no other drugs were administered and no history could be 
obtained that she had taken other drugs, Plumer concluded 
that the agranulocytosis was due to prontylin. Plumer'a 
cases is the first reported in which agranulocytosis 
has been attributed to sulfanilamide. Three months later, 
however, Young (132) reported agranulocytosis with fatal 
outcome in a man suffering from acute rheumatism, who had 
taken 3 grams of prontosil album for eithteen days. The day 
before death the total white count was 1800 with no neutro-
phils. A feature of the case was the failure of serial 
leukocyte counts to give warning of the impending disaster. 
The bone marrow shOled complete aplasiaat autopsy. the only 
benzene ring drug administered within twenty-four days of the 
development of agranulocytosis was sulfantlamide. 
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Less than a month after Young•s report, Model (82) reported 
the case of a man of ao, suffering from a recurrence of 
rheumatic fever. Three grams of .0proseptasine• (para-amino-
benzenesulphonamide) were gi~en for eighteen days and then 
discontinued. Two days later the leukocyte count was found 
to be 600 per cubic millimeter. In spite of blood trans-
fusions and pentnucleotides, death occurred the following 
day. ~odel said: dAlthough there is no proof that the agranu-
looytosis was due to the sulfanilamide, this case and Young's 
case suggest the advisability of a daily leukocyte cCllnt in 
cases in which this drug is given over long periods." 
Borst (11) reported a case of a woman, age 61, being 
treated for pyelocystitis. She received 6 tablets (300 mg. 
each) of prontosil flavum daily for nine days following which 
her urological symptoms subsided and the drug was stopped. 
About a week later, however, the symptoms reappeared and the 
drug was again prescribed in the same dosage for a period 
of eleven days after which the dosage was increased to 8 
tablets daily. A week later the patient complained of 
general discomfort, difficutly in swallowing and had a 
temperature of 102.2. A blood count at that time showed 
960 leukocytes per cubic millimeter with only one per oent 
polymorphonuclears. The patient died that day. Borst con-
cluded: 1 There can, I think, be no doubt about the close 
connexion between the use of prontosil flavum. and the 
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occurrence of a.granulocytosis in this case.• 
Jennings and Southwell-Sander (60) observed agranu-
locytoais in a 39 year old woman who suffered from ulcera-
t1 ve colitis. Sulfanilamide, 4.5 grams per day, had been 
given for three weeks and discontinued because her sy~ptoms 
had disappeared. Two days later evidence of agranulocyto-
sis began and increased inseverity for four days, when the 
total whit count was less than 400, none of which were poly-
morphonuolear cells. Under pentunucleotide therapy, there 
was a rapid rise in the polymorphonuclear count and general 
improvement and recovery. 1.his is the first case of agranulo-
cytosis attributed to sulfanilamide in which recovery has 
occurred. Schwartz and his associates (111) in January of 
1938, reported the case of aman of 33, treated for a penile 
ulcer with sulfanilamide over a oeriod of twenty-one days, 
during which time he took a total of 56.6 grams. The typi-
cal symptoms of agranulocytosis, with a leukocyte count of 
2000 and an absence of polymorphonuclear cells, developed. 
Ihey attempted to stimulate leukopoiesis by Ell intravenous 
injection of killed typhoid bacilli. The temperature in-
creased but the leukocytes continued to drop to 800 with an 
absence of granulooytes on the smear. The patient became 
increasingly toxic and died. The authors stated that they 
believed that sulfanilamide was the only drug that could be 
directly incriminated beeause the patient was in good general 
health proir to receiving the drug and then , coincident 
with the intensive a.dmintstration of it, granulocytopenia 
developed abruptly. They emphasized thatsulfanilamide has 
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a multiplicity of serious toxic properties, particularly with 
reference to the hemopoietic system and therefore that it 
should be administered only under careful observation and 
with frequent examinations of the blood. 
Berg and Holtzman (5) reported a fatal attack of agranu-
' locytosis in a man who took 38 grams of sulfanilamide in 
eleven days for acute gonorrhea. They state: 1 If there is 
any question as to whether sulfanilamide can induce the 
granulocytopenio st~te, this third reported fatal case adds 
it weight· to the belief that the relationship is acuually 
causal. 11 Jones and Killer (61). reported, in November, 1938, 
a oases of a man who had taken sulfanilamide for eight days 
following which he developed a fever and generalized ach-
ing pains. ': Two attempts to resume therapy were followed by 
a return of symptoms, the last time accompanied by severe 
neutropenia, with a total white blood cell count of 2,300 
of which only five per cent were neutrophils. The authors 
recorded the sulfanilamide concentration in the blood in 
relationship to the leukocyte count and concluded that there 
was apparently an "increasing susceptibility .to the drug". 
Allen and Short 4escribed a case in July, 1938, in which 
an eighteen year old school girl was treated by sulfanila.mide 
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therapy for a Bartholin's abscess, presumably due to the 
gonoooceus. The patient made a spontaneous recovery. She 
had received no other drugs 1 whivh might have been indicted 
as possible causes of granulocytopenia, so that aulfan1la-
m1de can be considered, at least presumptively, as the cause 
of her agranulocytosis.• 
It will be noted that these cases have all been report-
ed since April, 1937, and that the average age of the group 
is about 37 years and over half of the oases were in young 
adults, only three of which were females. !n every instance 
rather large amounts of the sulfanilamide eJ?.e administered 
before the disease made its appearance. Kracke (67) be-
lieves that this indicates that the mechanism of granulo-
poietio depression may be 41fferent from that following the 
administration of a single dose of aminopyrine. On the 
basis of his study of such cases, Kracke concluded~ •Sulfa-
nilamide should be added to the list of drugs that are 
capable of producint agranulooytosis.• He felt that because 
of the increasing use of this drug there will probably be 
an increasing number of cases of the disease following its 
administration. He said: 1 It is reasonable to assume that 
the market will shortly.become flooded with patented reme-
dies containing sulfanilamide and th t the dangers of agranu-
looytoais will become more accentuat 
In a study of the relation of d g therapy to neutro-
57 
pen1c states, Xracke (67), in October, 1938, drew attention 
to a chart whtmh he took from Plum's investigation of 
agranulocytos1s in Denmark. The chart reveals that the 
consumption of aminopyrine in Denmark before the disease 
made its appearance was practically nil, and that there was 
a gradual increase in the use of aminopyrine paralleling 
the increasing number of cases of agranulocytosis, the 
peak being reached in 1934. At that time the use of the drug 
was practically abandoned, and the·d1sease practically dis-
appeared. 
Kracke (67) has compiled a list of drugs and prepara-
tions that are known to be capable of producing agranulo-
oytosis. They are presented in tbe table below: 
*(A)Preparations that should be used with caution 




Amidol Amidotal Comp. 
Amido-Neonal Amifein 
Dymen &ardon 
Dys co Lumodrin 
Eumid Midol 
Gynalgos Myl1n 
Hexin Neonal Comp. 




























*Preparations listed under (A) contain aminopyrine. 
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Endogenou• Disturbances in the Bone Karrow.-- Accord-
ing to Beoj,(3) two different processes must be considered 
concerning the mechanism to maintain production and des-
truction of granulocytes at a constant level: 1. The mecha-
nism of delivery of cells to the circulation. ~1 a. The 
mechanism of maturation. As far back as 1927, Xastlin,(62) 
in discussing the pathogenesis of agranulooytosia, said: 
11 The hypoplasia of the granular cells is not a term1ilalJ. 
event and the decrease of the cells in the blood stream 
appears to be due to failure of development of the cells 
in the bone marrowff·. The early writers nearly all believed 
that the bone marrow in these cases was always aplastic. 
Leon (74), who wrote one of the first papers on this sub-
ject, in 1923, stated thatthe bone marrow did not contain 
leukocytes nor nyelocytes. However, Buck (14), in 192l, 
reported a case in which postmortem examination ef the 
bone marrow revealed evidence of acute hematopoiesis with 
cells normal in number and character and even myeloid 
hyper plasia. Kracke (66), in 1932, reported that he ~ad 
studied the bone marrow reaoved during life from five 
patients with agnanulocytosia and found 11 an apparent 
cessation of activity of the myelocytic elements and in 
some oases the complete absence of those elements•. 
Dameshek and Ingall (19), and Baldridge and Needles (a) 
were of the opinion that the bone marrow was not aplastic. 
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Thus the literature presented a picture of chaos as far as 
the pathology of the bone marrow and the pathogenesis of 
the disease was concerned. It remained for Fitz-Hugh and 
Krumbbaar (36), inl932, to clarify the situation. They 
reported a oase in which myelocytes and myeloblasts were 
found in the bone marrow at necropsy in more than normal 
numbers. The case was that of typical agranulocytosis, 
clinically, and the antemortem white blood cell count was 
200, all of which were lymphochtes. Bases on these find-
ings and similar ones recorded in the literature, these 
writers raised objection to the then current hypothesis 
of •granulocytic aplasia• as constituting the primary 
pathologic mechanism of the disease, and in its place they 
proposed the ~Jpothesis of •maturation arrest•. The 
following year, Fitz-Hugh and Comroe (35) reported that 
necropsy studies bad shown in more than half of the cases 
examined, by them, a plentiful supply in the leukopoietic 
centers of the progenitors of the blood leukocytes. They 
pointed out that this virtual hyperplasia was in marked 
contrast to the profound peripheral leukopenia character-
istic of the disease, and nstrengthens the previous sug-
gestion of an hypothesis of primary 1maturation arrest• 
rather than primary •aplasia' to aooount for the hemato-
logic phenomena of the disease." Thus these writers enter-
~tained the opinion that •agra.nulocytie angina exists as a 
60 
valid clinioopathologic entity in the same sense that per-
nicious anemia is accepted"• They explained that it was 
not many years ago that it was difficult to "defend the 
nosologio purity• of pernicious anemia but that it is now 
possible to exclude certain obscure pernicious-like anemias 
from the category of pernicious anemia by virtue of their 
failure to respond to adequate specific therapy. They 
concluded: "In a stmilar way agranulocytosis should be 
viewed as a disease entity which awaits the discovery of a 
specific therapy to stamp it with unmistakable validity.• 
It was from these observations that the authors suggested 
the name 1pernicious leukopenia0 , which suggests certain 
analagies between agran.ulooytosis and pernicious anemia. 
Beck (3) stated that in typical cases of ~ranulocyto­
sis there is a myeloic aplasia, and the part of the bone 
marrow that manufactures the granular leukocytes has ceas-
ed to function, or neraly so. She pointed out that the 
life of the granular cells in the blood stream in normal 
conditions of health is considered to be from three to five 
days; therefore, when manufacture of the granulocytes ceases 
and the supply of promyelocytes and metamyelocytes is ex-
hausted, the granulocytes of the blood stream wculd totally 
disappear in from three to five days after the exhaustion 
of the supply• Beck added that there was little evidence 
that the granulooytes are abnormally destroyed in the blood 
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stream and that the bulk of all evidence pointed to the 
fact that the primary lesion in these cases, so far as 
known, was in the granulopoietio areas of the bone marrow, 
and that this condition preceded the clinical symptoms 
and local infections. Therefore, Beck was dz~wn to. the 
same conclusion that was reached by Fitz-Hugh and Irumb-
haar (36), relating to a •maturation factor•. She said: 
"It seems reasonable to suppose that the primary lesion is 
not in the bone marrow but in the organ· or tissue which 
gives rise to the substance (factor) that keeps maturation 
of the granulocytes regulated to a normal level or regu-
lated so that destruction and production are kept constant.• 
In· the same paper,Beck (3) pointed out chat the textbook 
4esentpt1ons of pernicious anemia could be made to apply 
astonishingly well to this type of agranulocytosis, the 
prinQipal alteration being the substitution of the granulo-
poietio for the erytbropoietio tissue. Beck stated: "The 
maturation factor for erythrocytes has been foune. It now 
remains to find a maturation factor for granulocytes•. 
Similarly, Gordon (41) stated: 1 The cause of the disease 
may be a deficiency of some substance that will correspond 
to ventrioulin in pernicious anemia.• 
Roberts and Iracke (101) have presented a logical 
theory concerning the mechanism of the production of the 
disease, as follows; First, there is the onset in the 
bone marrow with a failure of myelocyt~c function. Thia 
may be due to myelocytic aplas1a or cessation of matura-
tion. Second, after a few days there' is an onset in the 
blood stream with a gradual dimtnution of the granulocytes 
until the number is g reatly reduced or they completely 
disappear. Third, there is the clinical onset, with the 
appearance of the characteristic symptoms. rourth, with 
a loss of protection, bacterial invasion begins and sixth, 
recovery or death occurs. 
In his review of the,present day findings and hy-
potheses of agranulocytosis in 1937, Thomas Fitz-Hugh (34) 
showed some dissatisfaction with the theory be origtnally 
introduced that a •maturation arrest• was the principal 
underlying factor in the pathogenesis of the disease. He 
stated: 1 The sudden changes in the granulooyte count of 
the peripheral blood (of •sensitized' individuals remak-
ing contact with a drug) occur too rapidly to be mediated 
by a •maturation arrest• mechanism.• Such sudden changes 
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he has referred to as •granulocytoclastio phenomena•. He 
explained that Clarke's work on the changes of the capillary 
endothelium might off er a possible mechanism for the sud.den 
changes in the granulocyte count. (Clarke and Clarke (15) 
showed by means of a glass rabbit's ear chamber, in which 
they could observe the cells within the capillaries, that 
minute stimuli of a mechanical, thermal or chemical nature 
resulted in changes of the endothelium which resulted in 
the adhesion of the leukocytes to the capillary wall.) 
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•one might hypothesize•, concluded Fitz-Hugh, •several such 
granulocytoclastic episodes might precede the final bone 
marrow arrest which in turn initiates the usual clinical 
syndrome.• 
PATHOLOGY 
In the previous section attempt was made to show that 
in the earlier writings there was m.uoh disagreement as to 
the pathologic picture of the bone marrow in agranulooyto-
sis. At the present time, however, there~ts quite general 
agreement that the bone marrow changes are variable. Boyd. 
(12) has summed up this view as follows: 1 As a rule it 
(the marrow) is aplastic and appears to be completely ex-
hausted, as is seen in experimental benzol poismning. In 
others it is normal, and in still others it may be hyper-
plastic.• Beck (3) stated that in practically all fatal 
cases the bone marrow was degenerated to a great extent, 
often licpid, and varied in color from red to straw. This· 
author also stated that there may ue areas of patchy 
necrosis in the marrow and that normoblasts and megakaryo-
oytea were present in their normal numbers, but the myelo-
oytes and polymorphonuolear cells were absent or nearly 
absent. Howerer, in 1936, Darling, Parker and Jackson (20) 
made an analysis of 25 typical cases of agranulocytosis 
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and concluded that '· as Fitz-Hugh and Krumbhaar (35) first 
suggested, in rapidly fatal oases the bone marrow shows 
stem cell hyperplasia and myeloid anakmesis,(the wort thay 
have given to maturation arrest)w1th01 t notable changes in 
the red oellrseries and that as the survival of the patient 
became longer the cells gradually and somewhat irregularly 
gave way to plasma cells and lymphocytes. They hypothe-
s1 zed that early in the disease there is a oompens.atory 
increase of the number of normally occurring stem cells 
(myeloblasts) in a vain effort to overcome the maturation 
arrest and that in the latter stages these stem cells dis-
appear and a coincident increase of lymphocytes and plasma 
cells occurs. They found that in the recovery stage there 
was a rapid development of the stem cells into myelocytes, 
metamrelecytes, and polymorphonuclear neutrophils. These. 
changes, in the authors• opinion, substantiate the previous 
contention of other investigators that the condition in 
the bone marrow is one of arrested maturation, 
There is little mention made in the literature of the 
pathology of agranulocytosis excepting that which refers to 
the changes which occur in the bone marrow. ' the sharply 
outlined necrotic lesions in the oral cavity and elsewhere, 
according to Ordway and Gorham, ( 86) are 1 characterized:'by 
a peculiar reactionlesa type of inflammation", that is, a 
complete absence of polymorphonuelear leukocytes, and only 
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a few lJmphocytes and plasma cells. These authors pointed 
out that such necrotic ulcerations may occur in varying 
degree, in the mou.th, esophagus, intestinal tract, vulva, 
vagina or skin. Beck (3) s,tated that it is possible that 
the lesions along the gastro-intestinal ~ract are affected 
by the usual bacterial inhabitants which gained entrance 
tothe tissues as a result of the removal of the protective 
mechanism of the granular leukocytes. 
The enlargement of the spleen in some cases has been 
found to be due to a great increase in the retioulo-endo-
thelial cells, which outnumber the lymphoid cells. The 
lymph follicles are small and atrophic, and there are no 
young cells or lymphoblasts in the germinal centers, only 
mature lymphocytes. The liver may be somewhat enlarged and 
show cloudy swelling. Microscopically, some oases have 
shown fatty degeneration, and occasionally small multiple 
foci of necrosis. The submaxillary, cervical, peribron-
chial and mesenteric lymph nodes are in general enlarged, 
and they sometimes contain hemorrhages. Microscopic ex-
amination reveals atrophy of the lymph follicles; there 
are no young lymphocytes in the germinal centers, only 
mature lymphocytes being present. There is a proliferation 
of the reticulo-endothelial cells. (3) 
SYMPTOMS, SIGNS, AND BLOOD PICTURE 
The clinical symptoms, -signs, and blood picture of 
agranulocytosis have been reviewed by roaq authors in the 
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literat\Jre, each presenting almost identical descriptions, 
the one phase of this condition in which there is, apparent-
ly, quite wide-spread agreement. For that reason only 
brief consideration will be given in this paper. Thompson's 
(125) description is typical; ~e onset of the acute case 
is abrupt, usually during good health. The first symptoms 
are fever and prostration. The temperature rises within 
a few hours to 104 to 105 degrees; malaise rapidly progress-
es to exhaustion. During the first one or two days these 
are often the only symptoms. A severe infection is suspect-
ed, but there is no subjective or objective evidence of 
localization. A diagnosis can be made at this stage only 
by the finding of the extreme neutropenia which has exist-
ed from the onset. Jaundice may or may not be present. 
The early writers stressed this finding as appearing in the 
majority of oases, but modern writers find that it is rare 
in typical oases. The end of the second day usually marks 
the appearance of the gangrenous lesions of the gums and 
throat. These begin as small discrete patches of edematous 
redness. They spread rapidly, the centers become ulcerated 
and necrotic, and they tend to coalesce into irregularly 
shaped areas of gangrene covered by a thick, tenacious, 
grayish white membrane; and surrounded by a similar rais-
ed, spreading, red margin. Similar ulcerations may appear 
in the rectum and vagina. As a rule there is relatively 
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little reaction in the neighborhood of these lesions, the 
contiguous lymph nodes are only slightly enlarged and a.re 
rarely tender. The spleen is not enlarged as a rule. (125) 
Jackson and parker (58) stated that the finding of an en-
larged spleen should indicate a leukemia instead of agran-
ulooytosis. Kastlin (62) found the spleen palpable in 33 
per cent of the oases. 
Although gangrenous stomatitis is by far the most 
frequent lesion, the infection may appear in various other 
places and assume various forms. Occasionally the lungs 
are the site of an extensive bronchopnelimonta; acute pyeli-
tis with pyelonephritis has been seen. Several instances 
of gangrenous vaginitis and endometritis have been report-
ed, as have cases of proctitis and perirectal abscess. 
Abscesses tend to develop during convalesence. '.L'he chronic 
form of the disease is characterized by a persistent leuko-
penia of from a,ooo to 4,000 with 25 to 50 per cent neutro-
phils. There is moderate malaise and weakness of a chron-
ic type. There is no angina or ulcerations except follow-
ing a period of extreme leukopenia and neutropenia when 
an acute attack is ushered in. (125) 
The typical agranulocytic type of blood picture pre-
sents few difficulties in diagnosis. There is a marked 
decrease in the total number of white blood cells, the 
counts ranging usually from 1,000 to 3,000 per cubic milli-
meter; white counts as low as 150 to 300 are not at all 
uncommon. Examinations of the stained smear shows a great 
scarcity of white blood cells. Kany low-power fields may 
have to be examined before a single cell is found. Of 
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the white cells that are seen, all, or nearly all, are 
adult, mature, small lymphocytes. A rare large lymphocyte 
and an occasional monocyte may be encountered. When com-
plete agra.nulocytosis exists, no polymorphonuclear leuko-
cytes are found. With the less severe degrees of depres-
sion, it is possible to find occasional granular cells, 
rarely more that ten per cent of the total number. The 
polymorphonuolear leukocytes, when found, are almost in-
variably adult, mature cells with a nucleus of from three 
to f1 ve lobes. Eoxinophils are a~sent as are the young 
forms of granulocytes. (Thompson (125)) 
Concerning the erythrocyte count,Sturgis and his 
associates (121) said: 1 There is rarely if ever a signi-
ficant degree of anemia.- When this is present it usually 
indicates that the leukopenia is associated withsome otber 
disease.• Jackson and Parker (58), however, pointed out 
that since the disease is most frequently found in middle-
aged to older women, the finding of a moderate degree of 
anemia would be of no great consequence. 
'!'here is a controversial point in regard to the 
blood picture as far as the platelets are concerned. the 
majority of observors agree that the number of platelets 
is normal or increased. Others believe the number 1e 
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reduced. Roberts and Kracke (101) stressed that a hemorr-
hagic tendency was common in the disease, whereas most ob-
servors have stated this finding is rare. Schult~ and 
Jacobowitz, (110)in'l925, emphasized the absence of hem-
orrhagic diathesis and thrombopenia and the practically 
normal erytb.ropoiesis as strict criteria for ·the diagnosis 
of the disease. Likewise,Jackson and Parker (58) stated 
that cases showing reduced platelets and marked anemia are 
probably acute leukemia or aplastic anemia. 
PROGNOSIS 
In the beginning the mortality of agranulocytosis was 
reported as 100 per cent. The first recovery from the dis-
ease was reported by Lauter,(71) in 1924, who reported the 
case of a young woman with 11 agranulocytic tonsilitis and 
stomatitis 11 • In 1927, Kastlin (62) reviewed the forth-
three cases he found in the literature and discovered only 
three recoveries or a mortality of about 94 per cent~ 
Harkins, (43) in 1931, found twenty-seven recoveries had 
been reported in the one hundred and fifty recorded cases, 
the approxiamte mortality rate being 82 per cent. Taussig 
and Schnoebelen (123) reviewed three hundred and twenty-
eight oases and found that the mortality was 75 per cent., 
without special therapy and with miscellaneous forms of 
treatment; 63 per cent with transfusions of blood, and 53 
per cent with roentgen treatment. Jackson and his co-
workers, (55) in 1933, reported a mortality of 30 per cent 
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in fifty-four typical oases in which treatment consisted 
of nucleotides. From these various reports, it would seem 
that the mortality rate has been steadily decreasing since 
1927. On the other band, Fitz~Hugh (34), in 1937, stated 
that his present mortality was 75 per cent. Similarly, 
Ordway and Gorham, (86) in 1937, stated that the mortality 
was "at least 75 per cent•. 
Very few patients recover if the total count falls 
below 1000. (3) Kracke (65) reported one case which 
showed a leukocyte count as low as 470 and recovered, only 
to die in a second attack. It is possible -that the appa-
rent decrease in mortality in some reports is due tottle 
fact that closer observations of the blood picture have 
cause some writers to include so-called "benign° or "chron-
ic" forms in their statistics. Ordway and Gorham (86) 
have pointed out that recovery from the first attack, with 
death in aseeond or third episode, may occur. They state 
that in general, the ,outlook will depend' -on the kind m d 
degree of marrow injury, the degree of secondary infection, 
and the general recuperative power of the bone marrow. 
TREA'l'MEN'l' 
There have been recorded many different suggestions 
as to the proper treatment of agranulooytosis. Kost 
authors, however, believe that- a specific and entirely 
satisfactory treatment has not been discovered. Kany 
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believe that recovery, when it does take plaoe, is spon-
taneous and not influenced by the type of treatment. Ham-
burger (42) reported a oase in a patient with 1500 white 
cells and two per cent neutrophils. This patient recovered 
in four weeks without any active treatment, and was still 
well five years later. In many cases in which recovery 
occurred,several types of treatment were used, so that it 
is impossible to draw decisive conclusion~ as to the effi-
cacy of the measures that were used, or to say which, if 
any, was responsible for the.cure. 
Treatment of Local Lesions.-- The most frequent 
complication of agranulocytosis is infection, local or 
general. The local lesions are most frequently found in 
the mouth and throat. All authors agree that the lesions 
require careful and intensive treatment. Babbit (1) stat-
ed, in 1930, that combined antiseptic and cauterizing 
measures should be employed. For a cauterizing measure, 
he prefers the use of 25 per cent trichloracetic acid and 
ten per cent neo-arsphenamine. He reported recovery in the 
case of a patient in which the leukocytes were down to 
600 with a complete absence of granulocytes. Hamburger (42) 
advised the following for local trea'tlment: After nourish-
ment, the mouth and throat are sprayed \11lith a saturated 
solution of potassium chlorate. Following the spraying, 
each ulcerated area and the gums are swabbed with a solution 
of copper sulphate, 10 grains to the ounce. This oral 
treatment is given as often as five times a day, and 
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less frequently as improvement takes place. It is ob-
vious that in the absence of granulocytes no frank abscess-
es will form but with the onset of recovery and the return 
of these cells to the blood stream such lesions are not 
uncommon. Any abscesses that form, of course, should have · 
proper surgical incision and drainage. Beck (3) empha-
sized the importance of refraining from any surgery in 
these patients that can be possibly avoided. She stated 
that such a procedure may bring about sluughing of tissue, 
as healing cannot take place.normally in the presence of· 
leukopenia and neutropenia. 
Miscellaneous Agents Used.-- The use of Neo-araphen-
amine, intravenously, was mentioned by MoQre a.nd Wieder, 
(83), in 1925. Rosenthal (103), in 1930, advised the use 
of neo-arsphenamine and blood transfusions. His series 
at that time showed six recoveries in fifteen cases. 
However, such treatment would certainly seem paradoxical 
in the face of Farley's (32) finding of thirty-nine oases 
recorded in which the function of the bone marrow was de-
pressed following the use of various preparations of ars-
phenamine. Diphtheria antitoxin, intravenous merourochrome, 
iron, arsenic, streptococcus sermn, typhoid vaccine, and 
other forms of foreign protein, have all been tried with-
out apparent success. (40)(114) Intravenous injections 
of gentian violet and acriflavine have veen tried with 
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the idea that there was a blood steam infection. (3) 
Roberts and Kracke, (lOl)in 1934, said: "Sepsis and ne-
crosis are the great hopes of every patient with complete 
granulopenia". This was bases on the theory that these 
conditions stimulated the·myeloblastio·aotivity of the 
marrow and thus caused leukocytosis. They believed that 
in cases without sepsis and necrosis that one would not be 
doing wr~ng to inject living staphylococci into the skin. 
They have shown that turpentine intramuscularly in a rabb-
1 t causes necrosis and leukocytosis and have used this 
treatment on one hWllan case with good results. Jackson (54) 
condemned sepsis as a therapeutic agent as there is •no. 
evidence that it.can stimulate a paralyzed bone marrow•. 
Strumia, (119), in 1934, pointed out that the reaaon~for 
the good results reported in some oases in which X-ray 
therapy was used, was the destruction of a number of cells 
and the liberation of disentegrating products. It occured 
to him that injections of leukocytes intramuscularly in 
oases of agranulooytosis might furnish such prod~eta of dis-
integration, •containing large amounts of nucleic acid salts 
in a form probably well tolerated and active•. He therefore 
prepared a 1 leukocytic cream• from human whole blood. He 
said: 1 011nioal response and the hematologic improvement 
follo-wing the injections of leukocytio cream have been, on 
the whole, strikingly parallel, and have progressed con-
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tinuously after they have begun.• Blanton (6) reported 
a case with recovery in which be gave 50 cc. of leukocytic 
extract daily. Sturgis and bis associates (111) stated 
that there was no evidence that leukocytio cream was of 
therapeutic value. 
Splenectomy was perform.ed in one case reported by 
Baldridge and Needles (a), in 1931. The patient died 
thirty-five days after the operation. There was not the 
usual rise leukocytes after the operation seen in other 
cases, but there was the usual platelet response. At ne-
cropsy the bone marrow showed an overgrowth of myelocytes 
and myeloblasts almost as marked as in myelogenous leu-
kemia. 
Karberg and Wiles, (79) in 1938, reported seven oases 
of agranulocytosis which were treated with yellow bone 
marrow concentrate per os. All Gf the patients recovered. 
Whether used alone or jointly with other medication 1 it 
usually causes a response in forty to forty-eight hours.• 
From their-clinical tests t~ese authors have concluded that 
the yellow bone marrow concentrate contains a substance or 
substances which act to stimulate the maturation or libera-
tion of leukocytes of the granulooyte series. They stated 
that their results bad confirmed the fundamental clinical 
observations c. H. Watkins, of the Kayo Clinic, made on 
patients treated with whole yellow bone marrow. They added 
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that the concentrate they developed contained the active 
principles without the bulky .inert neutral fa.ts which made 
the whole bone marrow unpleasant for clinical use. 
Blood Transfusions.-- Transfusions have been used in 
many of the reported oases, some of the patients recovering 
and others dying. There can be no definite conclusions 
drawn as to its efficacy because in practically all oases 
other measures were used along with the transfusions. There 
can be no great argument made in defense of transfusions as 
there is no convincing evidence that they will actually 
stimulate granulopoiesis. Certainly the number of cells 
would be small as compared to the amount n~eded. Doan (26) 
supplied a possible defense for the advoeates of blood trans-
fusions when he pointed out that it had been shown that he 
normal blood contains nucleotides and the neutrophils on 
diatntegration yield nucleic acid. Thus in transfusion 
11 an addition is made of the active principle". He hastened 
to add, however, that the concentration is very small and 
would probably be insufficient in severe cases of myeloid 
hypoplasia. Jackson (54) is 11 deoidedly against transfusion" 
stating that in some instances the white blood cell count 
may fall following them. In spite of these facts, many 
men have used this form of therapy and are stilil. using it. 
Such a use would seem to be essentially empirical. How-
ever, such writers as Ordway and Gorham (86), in 1937, 
advised frequent small transfusions as a supportive 
measure, and Sturgis and his co-workers (121) stated 
that "multiple small transfusions of blood may be bene-
ficial". Meyer and Rosenberg, (80) after reviewing the 
literature concluded that transfusicns seem to give 
favorable results. 
Irradiation of Bones.--Friedmann, in 1927 first 
reported the results of irradiation. At that time four 
of his cases showed improvement. A year later he re-
ported two more. Kore recently Friedmann has reported 
a series of 43 cases treated exclusively by X-ray. Of 
these 13 were reported as cured. He selected one-twen-
tieth of an erytherma dose as the proper dosage based 
on the Arndt-Schultz law that "small doses stimulate, 
large doses destroy.• (127) From the cases in the litera-
ture it is appa~ent that this dosage has been quite uni-
versally accepted·. Waters and Firor ( 127), stated that 
a variety of voltage factors have been used, from 130,000 
to 200,000 volts. In 1931, these authors reported the 
cases of five patients treated with roentgen rays; four 
were still living and the other was moribund when first 
seen. Their technic was as follows: The lower extremi-
ties, the pelvis, the upper part of the humeri, and the 
shoulder girdles were irradiated in the course of three 
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or four treatments. Voltage values of 200,000 with al-
uminum and copper filtration, both separately and com-
bined, with effective wave lengths ranging from 0.197 
to 0.161 angstrom units, were used. The measurement of 
dosage was effected by a dosimeter reading in roentgens, 
600 units being adopted as the erythema dose, which was 
agreed on at the Internation Conference of Radiologists 
at Stockholm in 1928. These writers explained the r.ationa.le 
of X-ray treatment by pointing out that the marrow in the 
shafts of the long bones in the adult consists mostly 
of adipose tissue with little or no blood forming function. 
Also that when excessive or pathological demand exists, 
there is a formation of new centers of differentiation 
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of the myeloblasts into granular myelocytes, the adipose 
tissue of the bone marrow being replaced by this newly 
formed tissue. They believe that it is possible that 
irradiation might aid in the formation of this new tissue. 
They concluded: •The results of irradiation of the bone 
marrow in angina agranulocytica, though not definitely 
acertainable as yet, justify, in our opinion, a trial of 
such therapy whenever possible for the unfortunate patients. 0 
Doan (26), in 1932, believed that X-ray was theoretically 
correct on the basis that if maturation arrest is present, 
irradiation might work by "first destroying some of the 
myeloid foci and thus release some of the autogenous-
nucleotides which then supply the necessary stimulus 
for maturation.• He stated, however, that because of 
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the potentially destructive affinity of irradiation for 
hematopoietic tissue, this form of therapy must be used 
with great caution when stimulation is desired. Taussig 
and Sehnoebelen (123) reviewed the literature as to the 
results of the various treatment, and, in 1931, reported 
that the lowest mortality rate was found in those patients 
who had been treated by irradiation. They said: 1 0f the 
methods of treatment at present in use, the most promising 
appears to be the irradiation of the long bones by means 
of minimal doses of X-rays. Jackson (54) stated that 
Roentgen therapy was useless. Witte (131), in 1936, stated 
that in his opinion Roentgen, and other forms of treat-
ment, were not specific therapeutic agents. Ordway and 
Gorham (86), stated: 1 Tbe stimulating action of X-ray 
bas been suggested but has proved of li~tle value, and 
may even be harmful." At the present time there seems 
to be few advocates of Roentgen therapy for agranulocy-
tosi s. 
Liver Extract.--In 1931, Harkins (43) reported two 
cases of agranulocytosis that recovered following the 
use of liver ext.r-1\0_t as the chief therapeutic agent. 
Foran and hie associates (37) reported remissi6ns in 
all five of their cases followin liver extract therapy. 
One died later in a recurrence during an attack of 
lobar pneumonia; the other four have ~emained well. They 
said: 1 The resemblance of the leukocytic increase to 
the retioulocyte rise in pernicious anemia was very stt1k~ 
ing in four cases.•. They used the equivalent of 100 
grams of liver every eight to twelve hours intramuscularly 
or intravenously. Jackson (54), in 1931, said: •At 
present the ultimate value of liver therapy in agranu-
looytosis cannot be estimated. It can only be said that 
a few patients have been successfully treated. •Ordway 
and Gorham (86), in 1937, stated that liver extract may 
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be effective. They advocate that it be given intramus-
cularly in large doses, 300. of concentrated liver extract 
every three hours, amounting to 10 or 12 cc. daily. They 
suggested that frequent white blood counts be made during 
the day 1 to guage the effect•. They observed that results 
apparently vary widely according to different writers; 1 in 
some instances brilliant success has been reported, in other 
cases, disappointing failure.• Parker and Kr,cke (87) 
made determinations on various preparations of liver ex-
tract and found the presence of a large amo'1nt of reduced 
glutathione. They suggested that this substance may_ be 
partially responsible for the therapeutic effect of liver 
extract in some of the leukopenic diseases, based on 
their experiments which showed a depletion of gluta-
thione in the bone marrow and blood of animals with a 
depressed bone marrow. Murphy (84), in 1936, reported 
that he had treated six typical cases of agranulocyto-
sis with daily, or more frequent injections of liver 
extract, with recovery in each instance. He believes 
that usually liver therapy has not been adequate where 
recovery has not followed. However, he considered that 
sufficient evidence had not been furnished to establish 
such therapy as the treatment of choice, but suggested 
that further experience may demonstrate that this pre-
paration is •as valuable in the control of this disease 
as it is in pernicious anemia.• 
Nucleotide Therapy.--The nucleic acids are present 
in the nuclei of cells of the animal body. According to 
the prevailing view, the nucleic acids are combined 
with protein, thus constituting the so-called nuoleo-
proteins. On partial hydrolysis, n~cleoproteins yield 
a protein residue and a protein-nucleic acid complex 
which has been called nuclein. If the cleavage is carried 
somewhat further, the nuclein yields protein and nucleic 
acid as cleavage products. Of the foodstuffs, glandulaz 
tissues, such a thymus, pancreas, liver, and kidney, are 
especially rich in nucleic acid. On hydrolysis nucleic 
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acid yields purine and pyrimidine nucleosides and phos-
phoric acid. The purine nucleotides on further hydrol-
ysis finally yield the purine bases, adenine and guanine. 
(Bodansky ( 9). 
Doan (26), in 1932, stated that nuclein therapy was 
suggested, on purely empiric groilnds, as early as 1893, 
to •increase the germicidal power of the blood in diseases 
of m1crobiD origin!• He stated that it is now known that 
the increase in leucocytes reported and attributed to 
nucleic acid in the earlier investigations was well within 
the normal range of physiologic fluctuation and not of 
sufficient magnitude to influence any pathologic process. 
Doan and his associates (28), in 1928, obtained a definite 
and usually considerable leukocytusis following intra-
venous injections of one gram of sodium nucleinate into 
normal rabbits. They found that a preliminary leukopenia 
occurred, sometimes lasting for a number of hours, which 
they attributed to a temporary storage of the granulo-
cytes in the spleen. In 1924, Jackson (52) demonstrated 
the existence of pentose nucleotides in normal human blood. 
Doan and his co-workers (28) secured adenine and guanine 
nucleotides from Jackson's laboratory, and chemically 
pure crystalline adenylic and guanylic acids from P. A. 
Levene of the Rockefeller Institute. All of these pro-




liminary leukopenia. Reznikof:f' (96), in 1930, reported 
the first clinical application of nucleic acid deriva-
tives. He stated that, since the other blood elements 
are usually not affected, this disease should lend it-
self to treatment by 1 the stimulation of the polymor- . 
phonuolear elements by nucleotides such as adenine suf-
late and guanine hydrochloride.• He reported three oases 
with recovery by the administration of 0.5 gram of the 
nucleotide twice 1n twenty-four hours. He found that 
within six hours there was some response and usually the 
increase in·granulocytes was marked after the second dose. 
In 1931, Jackson and bis associates (52) reported re-
covery in fourteen out of twenty oases of profound leu-
kopenia following large doses of nucleotides. The used 
the unbroken pentose nucleotide, called K-96, which was 
prepared by Smith, Kline and French Company. In the 
patients who recovered the first sign of improvement 
occurred between the third and seventh day, usually on 
the fifth day. The total and differential counts were 
invariably normal in ten days, S?metimes in eight. These 
writers commented: 1 Tbe consistency with which the re-
action ooctirred on or about the fifth day is of great 
significance. It is at this time that the reticulooyte 
rise begins to take place following liver therapy in per-
nicioue anemia. "This reaction would tend to show that 
the time for the maturation of the granulocytes is abcnt 
the same as that of the erythrocytes. Howe~r, Beck (3), 
in 1933, stated that there was no definite experimental 
proof, that nucleotide K-96 supplied a maturation factor 
for granulocytes. Doan (25), experimenting on normal 
rabbits with pentose nucleotide, in 1932, produced not 
only an extensive degree of myeloid hyperplasia, but also 
an extramedullary myelopoiesis in the kidneys and spleen. 
He (25), later, stated that the average effective dosage 
of Nucleotide K-96 in human cases of agranulooytosis had 
been four to six grams in his experience at that time. 
He stated that the experimental studies he had made on 
normal rabbits justified three conclusions: (1) Nucleic 
acid and its degradation products exert a chemotactic 
effect on normal myeloid foci with a prompt effective 
increase in the delivery of granular leukocytes to the 
peripheral circulation under a controlled physiologic or 
rhythmic mechanism; (2) Repeated large intravenous in-
j ecticn s do not tend to exhaust nor cause a malignant 
hyperplasia of the myeloid elements in normal animals. 
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(3) A short course of injections stimulates a myeloid hy-
perplasia of normal marrow without otherwise injurious 
consequences. Attenticn should be called to the fact that 
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Doan admitted that hie experiments were done upon normal 
animals. To draw conclusions as to the possible effect 
of such therapy in the case of human agranulocytosis 
hardly seems logical. Doan (26) based his work on the 
hypothesis that the degradation products of senile and 
disintegrating cells are an integral part of the normal 
mechanism for maintaining cellular equilibrium in the 
Marrow and the blood stream. He, therefore concluded 
that in those oases "presenting an etiology essentially 
intrinsic and related to an insufficiency of the myelop- . 
oietic function of bone marrow, the more rational treat-
ment should be the supoly to the body of a concentrated 
preparation of the active principle affecting directly 
the myeloid centers•. Doan included the following table 
to show the efficacy of nucleotide therapy. These figures 
are based on the literature to 1931: 
Therapy Oases. Deaths Mortalitl 
l. Untreated Many 96 % 
2. Miscellaneous 179 133 7, ~ 
3. Arshpenamine · 33 24 72 ~ 
4. Blood Transfusion 53. 34 64 ~ 
5. Irradiation 64 34 53 ~ 
6. Nucleotide 44 ll 25 ~ 
In 1933, Jackson (55), reported that he began treat-
ing systematically oases of agranulocytosis and "malig-
nant neutopenia secondary to sepsis• with pentoae nucleo-
tides (PentnucltWtide, N.N.R., formerly Nucleotide K-96). 
He stated that he had treated, or had reported to him, 
91 cases treated with pentnucleotide with a mortality 
of but ~. However, he emphasized the tendency to re-
lapse and the possible. occurrence of d!ath in the second 
or third attacks. In the usual case of agranulocytosis, 
Jackson uses 10 cc. of pentnucleotide intramuscularly 
two or three times daily until the white count has de-
finitely risen. Thereafter 10 co. are given once a day 
until the white count has been normal for three succes-
sive days. He recommends l'arger doses in the most severe 
oases up to as much as 40 cc. per day. Given intramus-
cul a:rly this preparaticm usually produces no marked unto-
ward reactions although there may be some local pain and 
not rarely there is nausea or vomiting shortly after ad-
ministration. Jackson pointed out that no definite bene-
ficial results are to be expected before the fourth or 
fifth day. 
!n 1933, Reznikoff (97), reported fifteen oases of 
agranulocytosis in which he used adenine sulphate. There 
was total recovery in eleven patients and almost all of 
them showed response in twenty-four hours. He used, for 
an adult, one grain of adenine sulphate boiled in 35 to 
40 cc. of physiologic saline, administered by vein three 
times per day for a least three days. This writer empha-
sized the faot ~hat in a disease such as agranulocytosis, 
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spontaneous recovery is so common that any evidence such 
as he has reported may be only circumstantial. 
Jackson, Parker, and Taylor (59) made an analysis, 
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in 193.2, of 69 oases of malignant neutropenia treated with 
pentose Nucleotide. (K-96) and found that 74 per cent of 
the patients had recovere~. · They stated, 1 The favorable 
clinical and hematologic response took place rather 
. '! 
sharply about the fifth day of treatment, irrespective 
of how long the patients had been ill. Sturgis and his 
' 
associates (121) concluded, in 1935, that there was more 
data in support of the effectiveness of pentnuoleotide 
therapy than of any other form of treatment. The report 
of Jackson and Parker (58), in 1935, offers more con-
firmatory data. These authors reported a series of 103 
patients treated with Pentnuolebtide (N.N.R.) in which 
the mortality rate was but 33 per cent. Jackson (54), 
in a later paper, written in the same year, suggested 
that one reason that some unfavorable results with pent-
nucleotide had been reported was because less than 40 cc. 
daily, his reeommended dose, had been given. He admitted 
that, unfortunately, this dose may cause such severe re-
actions in some patients that it cannot be tolerated. Be 
'.-' 
added also that a complete absence of granulocytes in the 
peripheral blood is probably incompatible with life and 
therefore despite an adequate dosage, the patient may die 
before the beneficial result occurs. Of all forms of 
treatment discussed thus far, the reports of cases and 
series of cases treated with nucleic acid derivatives 
· would certainly indicate that that form of therapy comes 
the nearest to being of value in agranulocytosis. There 
are on the other hand, several observors who have failed 
to note ~Y benefit .from such treatment. In 1937, litz-
Hugh (34) reported ·that the treat1nent in his hands had 
been of no apparent value. Howev.er, he stated that a 
possible explanation for.his failure lay in the fact that 
he did not stop the use of such drugs as aminopyrine in 
his oases until after the report of Madison and Squier 
in 1934. In Witts' (131) opinion neither pentnucleotide, 
transfusions, liver extract nor Roentgen treatment are 
specific therapeutic agents. 
Preventive Treatment.-~There was little definite in-
formation in the literature concerning the prevention of 
agranulocytosis or the prevention of re·currence of acute 
attacks until after 1931 when R. R. Xracks first drew 
attention to the possible etiologic importance of certain 
benzene ring drugs. Roberts and Kracke (lOQ, who found 
an incidence of a mild granulopenia in one out of four of 
a,ooo private ambulatory patients, stated that the com-
plaints of weakness, exhaustion or fatigue were twice as 
frequent in such patients as in those with normal white 
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cell counts. From this finding it would seem that rest, 
and freedom from mental and emotional strain, would be 
advisable in patients showing a low granulocyte count as 
a possible preventative measure against the development 
of agranulocytosis. With the great accumulation of data 
. ' 
supporting the etiologic relationship between certain 
drugs (related to aminopyrine or the benzene ring), and 
the disease under discussion has lead the majority o~ 
authors to the opinion that all such drugs should be with-
. ' 
drawn in the event of beginning development of granulo~ 
penia. Jla.ny authors go further and say that such drugs 
should not be used or should be used only rarely and 
sparingly. Kracke and Parker (69) expressed the belief, 
in 1935, that the most valuable therapeutic measure for 
agranulocytosis is to refrain carefully from the use of 
drugs containing aminopyrine. Fitz-Hugh (34), in 19a7, 
reported that in his series of such patients the 'best re-
sults, as far as therapy was concerned, were in the group 
of patients who stopped ingesting aminopyrine. He said: 
•It would seem reasonable that the earlier the diagnosis 
is established, and the earlier the offending drug is 
stopped, the better the outlook.• 
Kracke, iS7) in 1938, expressed the views of the 
majority of writers when he wrote that in an effort to 
to control the incidence of agranulocytosis, the physician 
should refrain from the use of aminopyrine or analgesic 
agents that contain it; second, he should warn his pa-
tients against the dangers of self medication, parti-
cularly the purchase and use of pain-relieving remedies 
for which the formula is not available; third, the phy-
sician who is using agents such as sulfanilamide in the 
treatment of severe infectious states, or is using 
arsphenamine and other organic arsenicals, should watch 
the patient carefully for signs of .possible hematologic 
depression by frequent studies of the blood; fourth, 
the physician should take an active part in the program 
of public instruction relative to the dangers of these 
preparations, for only if he does so can the public be-
come informed as to these dangers. Certainly it will not 
get this information from drug stores and pharmaceutical 
manufacturers. 
SUYM.ARY 
1. The term agranulocytosis, although criticized by 
numerous writers because of its intrinsic ambiguity, has 
become so firmly imbedded in the medical literature ·and 
the vocabularies of the clinicians that it is believed 
that it should be retained. The various other names sug-
gested are, admittedly, more descriptive and perhaps more 
accurate, but a common brief term, universally accepted, 
will always be more desirable. 
2. Although there was no great interest in the dis-
ease until after the appearance of the original article 
by Schultz, (lOS) in 1922, data has been offered to show 
that there is no reason to believe that the disease did 
not exist prior to that time. 
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3. The report of Lovett, (76) in 1924, of the first 
case in this country, Kracke's report of a case, (49) in 
1931, in which the relationship of coal tar drugs was first 
stressed, Fitz-Hugh and Krumbhaar•s suggestion, (36) in 
1932, that a maturation arrest was the principal pathology, 
and Plumer's (93) report of the first case due to sulfanil-
amide, in 1937, are other high points in the history of 
agranulocytosis. 
4. The numerous theories of the etiology and patho-
genesis have been discussed at some length. One definite 
conclusion can be drawn from the voluminous literature on 
this subject: There is, although gradually being reduced, 
a certain number of cases of agranulocytosis in which the 
cause cannot be determined at the present time. 
5. Biopsy and autopsy studies have confirmed, in 
the minds of most authorities, that there is present in 
the bone marrow an arrest of the maturation of the granu-
looyte development not unlike the arrested maturation of 
erythrocytes in pernicious anemia. The cause of the ma-
turation arrest, however, remains obscure. 
6. Sufficient evidence has been presented, I be-
lieve, to incriminate certain drugs, notably aminopyrine 
and its derivatives, dinitrophenol, arsphenamine, and 
sulfanilamide, in a large number of oases. The mechanism 
by which such drugs produce the disease is not understood. 
The evidence does not show, however, that the drugs, per 
se, are toxic to all individuals. An allergic or idio-
syncratic phenomenon must be assumed on the basis of the 
available data. 
7. For the sake of completeness, a brief discussion 
of the pathology, symptoms, signs, blood picture, and 
prognosis of the disease has been included. 
91 
s. A review of the treatment employed for agranulo-
oytosis reveals that almost innumerable agents have been 
prescribed. The fact that spontaneous recoveries are known 
to occur make it difficult to draw defini-te conclusions as 
to the efficacy of the various forms of treatment. 
9. lucleotide therapy in adequate dosage, according 
to statistics, offers the best hope for the patient as far 
as active treatment is concerned. Recent good results 
with liver extract and yellow bone marrow concentrate are 
encouraging but not conclusive. 
10. The withdrawal of any drugs, eapecially those 
containing a benzene ring, which might possibly have an 
etiologic bearing on the disease is to be definitely 
recommended. Such passive treatment in many cases has 
resulted in the patient's recovery. 
11. Physicians should refrain from the use of amino-
pyrine drugs or analgesics containing it as much as pos-
sible. Close observation of the patient's blood picture 
during the administration of drugs containing the benzene 
ring is essential as a prophylactic measure. P~tients 
should be warned of the aanger of the indiscriminate use 
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